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1 Summary 
1.1 English Version 
 
The conserved and essential histone chaperone FACT (Facilitates Chromatin 
Transcription) reorganises nucleosomes during DNA transcription, replication and repair 
and ensures both, efficient elongation of polymerases and nucleosome integrity. In 
mammalian cells, FACT is a heterodimer, consisting of SSRP1 and SUPT16. Although 
the genetics and biochemistry of FACT are relatively well understood, it is not known 
whether it confers cell-type dedicated functions. However, genome-wide expression 
analyses across cell and tissue types implicate a role of FACT in maintaining an 
undifferentiated state. Here, we show that in mouse embryonic stem cells (mESCs), 
depletion of FACT leads to up-regulation and alternative splicing of pro-proliferative 
genes and key pluripotency factors concomitantly with hyper-proliferation of mES cells. 
Additionally, genes involved in neurogenesis are de-repressed in the absence of FACT, 
leading to faster progression of neuronal differentiation. To understand the role of FACT 
in regulating transcription at these loci, we performed MNase digestion of chromatin 
coupled to deep sequencing (MNase-seq) and Nascent Elongating Transcript 
Sequencing (NET-seq). Genes up-regulated upon FACT depletion, are characterised by 
loss of MNase-resistance just upstream of the transcription start site, suggesting that 
nucleosome deposition by FACT dampens gene expression. Finally, in combination with 
the NET-seq data, we show that this FACT-dependent nucleosome distribution at the 
promoter region is closely associated with strong uni-directionality of RNA Polymerase II 
towards the coding region. Taken together, FACT promotes Pol II governing through 
nucleosome deposition and thus enables maintenance of an undifferentiated state. 
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1.2 German Version 
 
Das konservierte und essentielle Histon-Chaperon FACT (Facilitates Chromatin 
Transcription) reorganisiert Nukleosomen während der DNA-Transkription, Replikation und 
Reparatur und sorgt sowohl für eine effiziente Bewegung der Polymerasen durch das 
Chromatin als auch für die Nukleosomenintegrität. In Säugetierzellen formt FACT ein 
Heterodimer, bestehend aus SSRP1 und SUPT16. Obwohl die Genetik und Biochemie von 
FACT relativ gut verstanden sind, ist es nicht bekannt, ob es zelltypische und spezifische 
Funktionen verleiht. Allerdings implizieren genomweite Expressionsanalysen über Zell- und 
Gewebetypen eine Rolle von FACT bei der Aufrechterhaltung eines undifferenzierten 
Zustands. Hier zeigen wir, dass in murinen embryonalen Stammzellen (mESCs) die 
Depletion von FACT zu einer Hochregulierung und einem alternativen Spleißen von 
proproliferativen Genen und Genen kommt, die entscheidend für die Pluripotenz sind. 
Gleichzeitig sind viele Gene auch mit der Hyperproliferation von mES-Zellen assoziiert. 
Weiterhin sind andere Genen, die an der Neurogenese beteiligt sind, in Abwesenheit von 
FACT hochreguliert, was zu einer schnelleren Progression der neuronalen Differenzierung 
führt. Um die Rolle von FACT bei der Regulierung der Transkription an diesen Loci zu 
verstehen, haben wir MNase-Verdauung von Chromatin, gekoppelt an Micrococcal 
Nuclease-sequenzierung (MNase-seq) und ‚Nascent Elongating Transcript-Sequencing’ 
(NET-seq), durchgeführt. Bei der zweiten Methode wird die Position der RNA Polymerase 
nukleotidgenau und genomweit wiedergegeben. Genen, die nach der Depletion von FACT 
hochreguliert sind, zeichnen sich durch einen Verlust der MNase-Resistenz 5’ der 
Transkriptionsstartstelle aus, was darauf hindeutet, dass die Nukleosomenablagerung durch 
FACT an dieser Stelle die Genexpression dämpft. Schließlich zeigen wir in Kombination mit 
den NET-seq-Daten, dass diese FACT-abhängige Nukleosomenverteilung an der 
Promotorregion eng mit einer starken Unidirektionalität der RNA-Polymerase II in Richtung 
der kodierenden Region assoziiert ist. Zusammengenommen läßt sich sagen, dass FACT die 
Aufrechterhaltung eines undifferenzierten Zustands durch die Positionierung von 
Nukleosomen und Regulation von RNA Pol II beeinflusst. 
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2 Introduction 
2.1 Chromatin and nucleosomes 
 
Chromatin is defined as a tightly packed and regulated nucleo-protein (DNA and 
histone proteins) complex that is readily accessible and can be found in the 
nucleus of eukaryotic cells. The basic functional repeating unit of chromatin is the 
nucleosome which is composed of ~147 base pairs (bp) of DNA wrapped around 
a histone octamer comprising of two units of each of the H2A, H2B, H3, and H4 
histones (Schematic 1). All histones are subjected to different posttranslational 
modifications such as acetylation, phosphorylation, methylation, ubiquitination, 
and ADP-ribosylation. These modifications affect the biophysical properties of 
chromatin and have been shown to either promote or inhibit the functions of other 
factors. In addition, chromatin structure and especially nucleosomal properties 
can be robustly altered via the replacement of canonical core histones with 
alternate histone variants (Talbert & Henikoff, 2016), establishment or eviction of 
histones from DNA by ATP-dependent nucleosome remodellers (de Dieuleveult 
et al., 2016), and covalent histone modifications (Zentner & Henikoff, 2013).  
Key biological processes in eukaryotic systems, such as development and 
differentiation, are constantly regulated by DNA-binding proteins that dictate 
transcriptional programmes in a cell-specific manner. Despite chromatin 
undergoing many transitions at many levels of biological organisation, three 
classes are identified, with regards to the chromatin aspects that affect epigenetic 
modifications;  
i) specific histone marks associating with either promoter or enhancer 
regions,  
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ii) selective localised access to regulatory elements (“open chromatin”) 
emerges as chromatin structures hinder entry to underlying DNA 
sequence motifs (Thurman et al., 2012) and  
iii) long-range interactions between enhancers and targets regulate the 
nuclear architecture (Sanyal et al, 2012). 
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The advent of genome-wide chromatin immunoprecipitation-based techniques 
(ChIP-chip or ChIP-seq) has enabled the mapping of a vast amount of global 
histone modifications and transcription factors in many model organisms. A 
particular interest has arisen on modifications that are enriched over cis-
regulatory elements. Trimethylation of H3K4 (H3K4me3) and H3K36 
(H3K36me3) is a mark highly enriched on the promoters and gene body of 
actively transcribed genes, respectively.  
Other marks, such as H3K27Ac and H3K4me1 are usually localised over putative 
enhancers. Impairment of methyltransferase complexes leads to drastic 
reductions in H3K4me3 and H3K36me3 levels but the impact on the 
transcriptional landscape is minimal, suggesting that transcriptional regulation is 
not directly regulated by histone marks (Zentner & Henikoff, 2013).  
In fact, it has been suggested that posttranslational modifications may function as 
regulatory modules to some extent. Indeed, establishment of H3K36me3 on the 
gene body area has been linked to nucleosome stability and repression of cryptic 
transcription (Keogh et al., 2005). In general, histone modifications augment 
changes in nucleosome occupancy mediated by transcriptional elongation and 
chromatin remodelling factors.  
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Schematic 1: Chromatin compaction model. The DNA double helix is wrapped around 
histones forming the nucleosome; the basic structure of chromatin. Depending on the 
sparsity of nucleosomes across the genome, chromatin can be characterised as open 
(euchromatin) or closed (heterochromatin). This DNA-protein structure further undergoes 
further compaction and forms chromosomes that fit into the nucleus and hold the all the 
genetic information of an organism. 
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2.2 Chromatin structure and dynamics 
 
The presence of histone marks also defines the status of chromatin; either highly 
active and permissive (euchromatin) or closed and repressive (heterochromatin). 
Despite the non-permissive nature of heterochromatin, structural repressive DNA 
domains vary from one cell type to another, hence defining this type of 
heterochromatin as facultative (H3K27me3). In contrast, constitutive 
heterochromatin (H3K9me3, and H4K20me3) is permanently non-accessible 
among different cell types and usually devoid of genes as it is established around 
the centromeric and telomeric regions of chromosomes.  
Over the past 20 years, genetic screens in flies, yeast, and plants have identified 
key factors responsible for chromatin-dependent gene regulation, such as 
heterochromatin protein 1 (HP1), Suppressor of variegation 3 –9 (Su(var)3–9), 
Polycomb (Allis & Jenuwein, 2016). Alas, the molecular function of these factors 
with regard to enabling a euchromatin to heterochromatin transition, and vice-
versa, remains elusive. 
A successful interaction of transcription factors (TFs) with DNA regulatory 
elements requires the reorganisation of nucleosomal structures. Such 
disturbances in the nucleosomal landscape can be easily mapped via the 
detection of DNA sequences characterised by increased nuclease accessibility 
(DNase hypersensitive sites - Thurman et al., 2012). These “chromatin-
permissive” events are dedicated to cell-specific functions and govern diverse 
transcriptional programmes.  
Apart from the “canonical” histones that comprise the core unit of the 
nucleosome, evolutionary mechanisms have led to the emergence of histone 
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variants that bestow chromatin with special properties in a locus-specific manner. 
Core and variant histones display major differences with regard to spatial 
organisation and temporal expression pattern along the linear genome, with the 
histone variant-containing nucleosomes exhibiting specific and unique 
distributions. Histone deposition and eviction are necessary in modulating 
chromatin organisation and ultimately, DNA template-dependent biological 
functions. Hence, the evolution of specific chaperones and ATP-dependent 
remodellers has been a critical component in catalysing the above changes in 
chromatin structure (Buschbeck & Hake, 2017). All chromatin remodellers share 
a conserved helicase-like ATPase motor that powers all subsequent remodelling 
actions. However, they lack strong DNA-specific binding motifs as opposed to 
TFs. A chromatin remodeller – DNA contact is mediated via nucleosome binding 
through their N-terminal domains.  
Given the nucleosome-specific function of remodellers, it is not surprising that 
functional interactions also exist between chromatin remodellers and histone 
modifications. Deletion of histone acetyltransferases (HAT) is synthetically lethal 
with loss of RSC (Remodels the structure of chromatin) or SWI/ SNF (SWItch/ 
Sucrose Non-Fermentable) (Kasten et al., 2004). It is tempting to speculate a 
synergistic effect between remodellers and histone modifications. 
  
Introduction 
 
14 
 
2.3 Chromatin dynamics in early embryogenesis 
 
Embryonic cells acquire a cellular identity right after fertilisation that enables them 
to commit to a specific lineage. Yet, it is unknown how chromatin conformation 
within each cell promotes this commitment throughout the whole developmental 
cycle. Nevertheless, it is postulated that embryonic chromatin structure regulates 
cell fate by operating at two levels via the regulation of genes coding for lineage 
specific TFs and the alteration of chromatin dynamics and nuclear organization 
on a global scale (Burton & Torres-Padilla, 2014). 
A de novo chromatin assembly right after fertilisation results in the incorporation 
of newly synthesised histones (mainly hyperacetylated and hypomethylated) 
deriving from the maternal genome (Burton & Torres-Padilla, 2014). Thus, the 
newly assembled genome is devoid of heterochromatin. This loss of 
heterochromatin is consistent with a more open chromatin conformation 
characterising pre-implantation development (Ahmed et al., 2010) and the 
maintenance of a pluripotent state. In general, it has been previously proposed 
that this “open” chromatin conformation allows transcriptional programmes to 
swiftly switch upon the induction of a differentiated cell state (Gaspar-Maia et al., 
2011).  
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2.4 Chromatin and pluripotency 
 
The idea of an open chromatin in ES cells has been initially supported by electron 
microscopy, where heterochromatin levels in differentiated cells exhibited 
significantly higher levels of compact chromatin compared to ES cells (Park et al., 
2004). In addition, ChIP-seq analyses of both constitutive (H3K9me3) and 
facultative (H3K27me3) heterochromatin marks further support the prevalence of 
a more “compact” chromatin in a differentiated state (Hawkins et al., 2010).  
The presence of active gene expression marks (H3K4me3, H3K27Ac) is more 
prominent in ES cells as opposed to somatic cells. However, there are counter-
acting mechanisms that repress developmental regulatory genes, and hence 
maintain a pluripotent state. These developmental regulators are usually poised, 
i.e. they are characterised by the presence of both active (H3K4me3), and 
repressive (H3K27me3) histone marks (Azuara et al., 2006; Pan et al., 2007). 
This bivalent state allows, during differentiation, the rapid expression of lineage-
specific genes through loss of the repressive H3K27me3 mark, or the repression 
of genes through the loss of H3K4me3. 
Moreover, apart from active histone marks, open chromatin in ES may be 
maintained by ATP-remodellers and histone chaperones via nucleosome 
assembly/ disassembly as well as the unwinding of highly ordered structured 
chromatin. Taken into consideration the high expression levels of remodellers in 
ES cells (de Dieuleveult et al., 2016; Efroni et al., 2008) along with the 
abundance of active histone marks, it is possible that this collaboration 
orchestrates an open chromatin state on a global scale. 
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2.5 Histone chaperones 
 
Core histones have the ability to bind DNA in vitro, thus resulting in the formation 
of a diverse array of chromatin structures. A proper co-ordination of histone 
dynamics with regard to the assembly of well-defined nucleosomes is being 
conferred by key factors called histone chaperones. Histone chaperones are 
involved in multiple steps of nucleosome formation and maintain histone stability 
or degradation (Burgess & Zhang, 2013). Potential functions involve;  
1) regulating interaction of histones with importins,  
2) direction of specific enzymes to histones for the establishment of specific post-
translational marks (PTMs),  
3) facilitation of intra-histonic interactions for nucleosomal formation and stability 
(Buschbeck & Hake, 2017). On the other hand, chromatin remodellers use ATP 
to catalyse changes in chromatin structure and can allow the exchange of core 
histones with histone variants (Narlikar, Sundaramoorthy, & Owen-Hughes, 
2013).    
Although histone chaperones share the common attribute of binding histones 
(either H3-H4 or H2A-H2B oligomers), a few of them can bind to specific histones 
(canonical or variants) alone (Obri et al., 2014). Despite this specificity, most 
histone chaperones play a crucial role in stabilising nucleosome oligomers in a 
free soluble state; a critical step for nucleosome formation. In addition, a 
collaboration between histone chaperones, and chromatin remodellers can 
influence gene expression by altering nucleosomal stability via canonical or 
variant histone deposition and thus enable/prevent the recruitment of TFs. 
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2.6 The histone chaperone FACT  
 
Several histone chaperones involved in nucleosome assembly have been shown, 
over the past two decades, to fundamentally alter chromatin structure, thus 
allowing crucial DNA-based processes such as DNA repair, replication, and 
transcription to take place by safeguarding non-nucleosomal histone-DNA 
interactions. They mainly bind to regions on the histones that are crucial for 
nucleosome formation, thus indicating a putative role in the stabilisation of 
oligomers in the free and soluble state adjacent to the nucleosome. In contrast to 
ATP-dependent remodelling factors, which use energy from ATP hydrolysis to 
disrupt histone-DNA contacts, nucleosome destabilisation by histone chaperones 
is mediated through the use of the spontaneous movement of the DNA around 
the dyad axis (Hondele et al., 2013). Moreover, histone chaperones, in tandem 
with ATP-dependent chromatin remodellers, deconvolute the organisation of 
highly ordered chromatin in order to enhance accessibility of cellular components, 
such as Pol II, thereby facilitating transcription (Venkatesh & Workman, 2015). 
The histone chaperone FACT (Facilitates Active Transcription) is a 180k Da 
heterodimer, comprising of SSRP1 (Structure Specific Recognition Protein 1) and 
SUPT16 (Suppressor of Ty 16) proteins, that promotes polymerase progression 
via nucleosome destabilisation (Belotserkovskaya et al., 2003; Orphanides et al, 
1999). Although the structure of FACT is highly conserved among eukaryotes, in 
yeast and fungi the SSRP1 subunit (Pob3 in yeast) lacks DNA binding affinity. 
Instead, DNA binding capacity is implemented by Nhp6 that loosely associates 
with the FACT complex and promotes its function in vivo; the displacement of 
H2A-H2B dimers to allow passage of the transcribing RNA polymerase (Winkler 
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& Luger, 2011). Interestingly, Nhp6 serves also as DNA binding mediator for 
other elongation factors, such as SPT6 (Suppressor of Ty 6). 
Deletion of FACT in yeast leads to inviability (Jeronimo et al., 2015) whereas a 
homologous deletion of Ssrp1 in mouse embryos compromises survival after 
preimplantation (Cao et al., 2003). Concomitantly, depletion of FACT in human 
cancer cells hinders cell proliferation indicating that FACT might serve as a 
potential drug target against tumorigenesis (Gasparian et al., 2011; Koman, 
Commane, & Paszkiewicz, 2012).  
Generally, in higher eukaryotes, FACT is highly enriched in stem and cancer cells 
while its levels are significantly reduced in differentiated cells. This suggest a role 
of FACT in maintaining an undifferentiated state (Garcia et al., 2011). 
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2.7 Transcriptional regulation by FACT 
 
FACT activity is crucial for transcriptional elongation and is enabled by two 
distinctive mechanistic models; (i) Histone removal in front of RNA Pol II, and (ii) 
nucleosome reassembly in its wake. The above processes have been elucidated 
in vitro and pinpoint; 
a) A strong affinity of FACT with nucleosomes via direct interaction with H2A-
H2B dimers that allows efficient transcriptional elongation (Orphanides et 
al., 1999). 
b) The disassembly of H2A-H2B dimers by FACT (Belotserkovskaya et al., 
2003). 
Corroborative evidence supports the above notion. In yeast, mutations that 
weaken the interaction between H2A-H2B and (H3-H4) tetramers can suppress 
defects in FACT function both in vivo and in vitro, reinforcing the role of FACT in 
promoting histone eviction (McCullough et al., 2011). A major debate in the field 
still rises with regard to whether H2A-H2B deposition is a directed and necessary 
result of FACT activity (Duina, 2011). As a result, apart from the orginal “dimer 
eviction model”, a second “non-eviction/ global accessibility model” suggests that 
the FACT-nucleosome complex results to tethering of all histone subunits in a 
specific conformation state that allows easier accessibility and loss of H2A-H2B 
dimers (Formosa, 2012). In this latter model, the eviction of H2A-H2B is not a 
consequence of FACT activity but instead it is mediated by extrinsic factors such 
as the force exerted by the elongating RNA Pol II. 
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2.8 Chromatin and FACT 
 
Previous reports pinpoint the involvement of FACT in transcriptional initiation and 
elongation through binding to the H3K4me3 mark, Chd1 chromatin remodeller, 
and Pol II (Sims et al., 2007). Moreover, FACT inactivation in yeast causes 
increased transcription through elevated Pol II and TATA-binding protein (TBP) 
occupancy (Mason & Struhl, 2003). This suggests a putative function of FACT in 
suppressing cryptic transcription at certain promoters.  
FACT is also influenced by the chromatin environment across transcribing genes 
by altering histone modifications. Mono-ubiquitination of H2B can mediate FACT-
dependent histone eviction during transcriptional elongation. On the contrary, 
mono-ubiquitination of H2A prevents transcriptional elongation by inhibiting FACT 
recruitment to chromatin (Zhou et al., 2008). Recently, it has also been observed 
that glutamine methylation (H2AQ105me) restricts binding of FACT on ribosomal 
DNA (Fig 1 - Tessarz et al., 2014).  
In addition to being a key contributor to transcriptional elongation, FACT is also 
involved in mRNA nuclear export (Hautbergue et al., 2009) as well as the efficient 
splicing of transcripts (Burckin et al., 2005). 
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Figure 1: FACT facilitates passage of the polymerase by remodelling chromatin. 
Methylation (me) of Gln105 (Q105me) in H2A prevents FACT from interacting with the 
H2A-H2B dimer and thus leads to decreased nucleosome reassembly in the wake of 
RNA polymerase I (RNA Pol I). Consequently, the formation of a more open chromatin 
takes place, devoid of nucleosomes, which ensures high levels of rDNA transcription. 
HMT, histone methyl transferase. (Taken from Tessarz & Kouzarides, 2014). 
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2.9 Transcription mechanics by RNA polymerase II  
 
RNA polymerase II (Pol II) is responsible for the transcription of DNA into mRNA 
with the aid of additional protein factors. Transcription is usually divided into three 
phases on the basis of the factors and the mechanisms that regulate Pol II. One 
of the most well studied mechanisms is the reversible phosphorylation of the 
largest subunit of Pol II; the carboxy-terminal domain (CTD) which contains a 
repeating heptapeptide sequence (YSPTSPS). The different factors and CTD-
phosphorylated residues that associate with Pol II in a stage-specific manner are 
summarised in Table 1. The initiation phase involves binding of Pol II (S5 ph) to 
the gene promoter region (Sainsbury, Bernecky, & Cramer, 2015), followed by 
the elongation phase, during which RNA synthesis occurs. Nevertheless, higher 
eukaryotes display an additional signal integration step that separates the two 
aforementioned phases and keeps the polymerase paused at promoter-proximal 
regions (Venkatesh & Workman, 2015). Transcriptional elongation is followed by 
termination, where the transcribed RNA is released from Pol II (S2 ph). This 
cyclic and continuous repetition of all three phases determines a gene’s 
expression levels and ensures normal cellular and organismal functions. 
The completion of transcriptional initiation does not necessarily guarantee a 
robust transition into transcriptional elongation. Pausing of RNAPII can be 
observed after the transcription of 20 and 60 nucleotides in almost 30% of the 
total human genes. However, this pausing is temporary, and hence allows Pol II 
to resume transcriptional elongation (I Jonkers & Lis, 2015). 
Pausing of Pol II at promoter-proximal regions is highly dependent on the core 
promoter features responsible for Pol II recruitment. This is accomplished via a 
synergistic effect between promoter-associated transcription factors (TFs), the 
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negative elongation factor (NELF), and DRB-sensitivity-inducing factor (DSIF) 
(Table 1). Phosphorylation of NELF/DSIF by the positive transcription elongation 
factor (P-TEFb) complex enables the release of paused Pol II and mediates the 
progression of transcriptional elongation. P-TEFb has also been shown to 
phosphorylate the elongating Pol II variant (Pol II S2), thus allowing promoter-
proximal pause release (Iris Jonkers, Kwak, & Lis, 2014) (Schematic 2). 
 
Although promoter-proximal pausing occurs in a wide range of eukaryotes, its 
function still remains to be elucidated. Jonkers and Lis (2015) propose three non-
exclusive models for its function: (1) The presence of a stalled Pol II is a 
characteristic of an active and open promoter; (2) Changes in gene expression 
are highly dependent on stimuli response. Therefore, gene expression can be 
accelerated by skipping transcriptional initiation and Pol II can enter a paused 
state. As a result, genes that display a higher paused Pol II will be activated more 
swiftly; (3) Due to co-transcriptional processing, Pol II is associated with several 
other proteins during transcription. The levels of pausing depend on a balance 
between pausing and activating factors. 
Transcriptional elongation is more complex than initially thought. Pol II elongation 
rates fluctuate between and within genes, and seem to facilitate splicing, 
termination, as well as genomic stability (Iris Jonkers et al., 2014). Transcriptional 
elongation by Pol II is a highly dynamic process and an indispensable part of the 
transcription cycle. ChIP of RNA pol II followed by sequencing, maps distribution 
of the polymerase across the genome and provides great insight with regard to 
RNA transcription. Nevertheless, caveats such as low resolution and vague 
strand specificity predominate. In addition, ChIP–seq of Pol II displays high 
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background levels on the gene body areas, and its use is restricted to highly 
expressed genes (I Jonkers & Lis, 2015). Hence, a number of techniques have 
been developed to study elongation rates on a genome-wide scale (Kwak et al., 
2013; Mayer & Churchman, 2016; Min et al., 2011). In Global run-on-sequencing 
(GRO-seq) and Precision run-on-sequencing (PRO-seq), Pol II is halted and then 
restarted in vitro under the presence of modified nucleotides that enable nascent 
RNA purification. Transcription run-on based methods are highly dependent on 
the transcriptional restart of Pol II under non-physiological conditions; thus 
avoiding detection of Pol II that is in the process of pause-recovery.  
Native elongating transcript sequencing (NET-seq) can capture nascent RNA 
transcripts at high resolution and detect unstable anti-sense transcripts before 
they are turned over by the cellular RNA degradation pathways (Mayer et al., 
2015).  This allows high resolution mapping of RNA polymerase (paused, 
recovering, and not paused) during initiation and elongation. It also enables the 
characterisation of distinctive regions of high Pol II pausing where splicing of 
RNA transcripts occurs.  
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Table 1: The CTD domain of Pol II serves as a protein-recruiting platform. Different 
phosphorylation statuses in the heptapeptide sequence (YSPTSPS) of the CTD domain 
of Pol II are crucial for transcriptional initiation, elongation, and termination. A diverse 
combination of kinases, histone chaperones, chromatin remodellers, and phosphorylated 
residues work in synergy for an efficient activity of Pol II (Venkatesh & Workman, 2015). 
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Schematic 2: Promoter architecture model. A typical eukaryotic promoter includes a 
nucleosome free region (NFR) upstream of the TSS where binding of most transcription 
factors (TFs) occurs. RNA Pol II is stalled by the NELF/DSIF. Its tail phosphorylation at the 
5th Serine (S5 ph) indicates proximal promoter pausing. When NELF/DSIF dissociates, Pol 
II is phosphorylated at the S2, thus marking its progression towards transcriptional 
elongation. Pol II can also transcribe on the opposite direction. However, those transcripts 
are immediately degraded by the exosome complex. 
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2.10 Alternative splicing of RNA transcripts 
 
Alternative splicing is defined as the process by which exons from a single gene 
can be either included or excluded from the final mature RNA (mRNA) product, 
making it an important regulatory crossroad between transcription and 
translation. Alternative splicing affects over 95% of all mammalian genes and 
multiple regulatory processes such as chromatin modifications and signal 
transduction (Kornblihtt et al., 2013).  
 The spliceosome is a multi-ribonucleoprotein complex that assembles at the 
splice sites of each intron and mediates the splicing process. A consensus 
sequence at each splice site is fundamental not only for recognition by the 
spliceosomal components but also for assessing the “strength” of the splicing site 
(Sibley, Blazquez, & Ule, 2016). The competition between “strong” and “weak” 
splice sites along the nascent pre-mRNA leads to alternative splicing of 
transcripts.  
The 5’ and 3’ splice sites mark the beginning and the end of each intron and 
undergo “cutting and sewing”. A combination of small nuclear ribonucleoproteins 
(snRNPs) U1, U2, U4, U5, and U6 and auxiliary factors (U2AF65, U2AF35) form 
the spliceosomal complex that performs two transesterification reactions 
necessary for intron excision and subsequent joining of selected exons (Fig 2). 
Together with RNA-dependent ATPases and helicases, the spliceosome 
transitions from an inactive to a catalytically active state. 
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Alternative splicing is more prevalent in multicellular eukaryotes suggesting its 
significant biological importance with regards to the vast expansion of coding 
capacity that it provides. This divided organisation of eukaryotic genes into exons 
and introns seems to have two advantages; 
- Formation of new genes via non-disruptive recombination events that 
allowed the fusion of protein-coding exons from different ancestor genes. 
This mutational process is known as exon shuffling enables new genes to 
carry over the splicing signals of the ancestor genes (Hynes, 2012). 
 
- Expansion of coding capacity of eukaryotic genomes. A single gene can 
produce two or more mRNAs that are very similar but not identical. 
Subsequently, this allows the translation of different proteins. 
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Figure 2: The spliceosome mediates a two-step splicing reaction. Initially, the 
branch site, the 5’ splice site, and the 3’ splice site are recognised by the branchpoint 
binding protein (BBP), the U1 snRNP, and the auxiliary factors (U2AF65, U2AF35), 
respectively. The first transesterification step involves a nucleophilic attack by the 2’ OH 
group of a key adenosine in the branch consensus site on the 5ʹ splice site. This results 
to the formation of a branched RNA intermediate known as the intron lariat as well as to 
the release of a subset of snRNPs. In the second transesterification step, the 3’ OH 
group of the upstream exon attacks the 3ʹ splice site, producing a fusion of the adjacent 
exons (spliced mRNA). The excised intron is subsequently degraded (Kornblihtt et al., 
2013). 
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2.11 Alternative splicing and transcription 
 
Similarly to other pre-mRNA processing events, splicing is coupled to 
transcription, in a way that both processes influence each other via co-ordinated 
mechanisms. One of those mechanisms is kinetic coupling, where the rate of Pol 
II-mediated elongation affects the pace at which splice sites and regulatory 
sequences appear in the nascent pre-mRNA during transcription. Sequences 
associated with Pol II pausing, promote retention of exonic cassettes in the 
mRNA (Nogue et al, 2002) whereas elongation-promoting factors increase Pol II 
speed and hence allow exon skipping (Roberts et al, 1998). Indeed, the idea of a 
slow Pol II facilitating inclusion of alternative exons is supported by global 
analyses where dozens of alternative splicing events are affected by the 
treatment of human cells with strong inhibitors of elongating Pol II (Ip, Schmidt, & 
Pan, 2011). Nevertheless, he effects of kinetic coupling on spicing are highly 
dependent on the microenvironment as well as the different combinations of 
splicing regulators. 
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Figure 3: Effect of transcriptional elongation on alternative splicing. During RNA 
polymerase II (Pol II)-mediated transcription, exon skipping is achieved via fast 
elongation (left) that aids the recruitment of the spliceosome to the strong 3ʹ splice site of 
a downstream intron instead of the weak 3ʹ splice site of the upstream intron. On the 
other hand, slow elongation (right) favours the recruitment of spliceosome components 
to the upstream intron, which results in splicing commitment and exon inclusion 
(Kornblihtt et al., 2013). 
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2.12 Chromatin and alternative splicing 
 
Over the years, increasing evidence pinpoints a key role of chromatin in 
alternative splicing of transcripts via the establishment of histone modifications 
and nucleosome positioning. The initial idea of chromatin structure affecting 
alternative splicing originates from studies in mammalian cells, where exonic 
inclusion was increased in response to DNA replication (Kadener et al., 2001). A 
more compact chromatin state would act as a barrier to Pol II elongation and 
promote high exonic inclusion as result of kinetic coupling.  
Histone post-translational modifications, associating with either active 
(H3K36me3, H3K4me2/3, and H3K9Ac) or repressed (H3K9me2/3, and 
H3K27me3) transcription, are known to be indispensable regulators of alternative 
splicing. In neuronal cells, membrane depolarisation leads to accumulation of 
intragenic H3K9Ac which subsequently promotes an open chromatin state, 
increased Pol II elongation, and as a result exonic skipping in the NCAM (neural 
cell adhesion molecule) gene.  On the contrary, during neuronal differentiation, 
the repressive H3K9me2 and H3K27me3 marks are highly enriched over the 
NCAM gene body, thus promoting exonic inclusion via compromised Pol II 
elongation (Schor et al, 2009) (Fig 4).  
Taken together, external signals and differentiation pathways are capable of 
altering chromatin structure and ultimately influence the alternative splicing of 
mRNA transcripts. 
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Figure 4: Effect of chromatin on alternative splicing. External stimuli as well as the 
differentiation state of the cell affect the chromatin state which in turn impacts alternative 
splicing decisions. Here, it is shown a collaborative mechanism between histone 
modifications and transcription with regards to kinetic coupling and splicing (Schor et al, 
2009). 
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3 Aims 
 
The function of FACT has been well characterised in both genetics and 
biochemical terms. However, its molecular functions in higher eukaryotes with 
regard to controlling transcriptional elongation and nucleosome occupancy are 
yet to be determined. Moreover, the means by which pluripotency is maintained 
in the presence of FACT are still unknown. In this project, we are trying to answer 
the following questions that will shed light to the molecular functions of FACT in 
mouse embryonic stem cells (mESCs); 
1) What are the putative DNA binding sites for both FACT subunits (SSRP1, 
SUPT16)? Do they have autonomous and/or distinctive function? 
2) How does FACT affect the transcriptional landscape? 
3) Can the above changes in the transcriptome be reflected at a proteomic 
level? Does FACT serve as a docking site for additional proteins/TFs? 
4) How is FACT involved in the integrity of the nucleosomal landscape? 
5) Is FACT a critical component in the production of nascent RNA and the 
productive elongation of Pol II? To what extent do nucleosomes affect the 
progression of the FACT-Pol II complex? 
6) Wrapping up all the above, can FACT maintain pluripotency? 
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4 Results & Discussion 
4.1 FACT correlates with active gene expression 
 
High expression of FACT is associated with stem or less-differentiated cells 
(Garcia et al., 2011). Indeed, we were able to confirm that diminishing levels of 
FACT correlate with the differentiation state of the cell. The highest FACT mRNA 
levels were observed for cancer and stem cell lines, whereas the lowest were 
observed for the potently differentiated ones (NIH3T3 & MEFs, Fig. 5a). We also 
employed RNA-seq data of ES to cardiomycte differentiation at different 
timepoints to assess FACT levels (Wamstad et al., 2012). Indeed, both levels of 
Ssrp1 and Supt16 are reduced with the priming of ES cells towards a 
differentiated state (Fig. 5b) Thus, we chose to explore the means by which 
FACT maintains an undifferentiated state. 
 Initially, we applied to mESCs a chromatin immunoprecipitation and sequencing 
(ChIP-seq) assay to identify potential DNA binding regions for both FACT 
subunits. Both SSRP1 and SUPT16 proteins displayed high similarity in binding 
capacity with the highest correlation observed over the gene body area of all 
genes (Pearson’s correlation = 0.96, Fig. 6a), thus confirming their association to 
each other with regard to forming a protein complex.  
Subsequently, we examined FACT co-enrichment with several other transcription 
factors, histone marks, and chromatin remodellers over the gene body area of all 
annotated genes (n = 13,348). High correlation scores were observed between 
SSRP1, SUPT16, H3K4me3, H3K27ac, and Pol II variants (Pol II S5ph, Pol II 
S2ph) confirming the role of FACT in active gene expression (Fig. 6d & 7a). A 
good correlation was also observed between both FACT subunits and Chd1, in 
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line with data demonstrating physical interaction and co-localization in 
mammalian cells (Kelley, Stokes, & Perry, 1999). However, a lower correlation 
was observed between FACT and H3K36me3 on a genome wide level. 
H3K36me3 has been shown to be able to directly recruit FACT to actively 
transcribed genes (Carvalho et al., 2013). We suspect that the enrichment of 
FACT subunits around the TSS might mask this potential correlation as FACT 
subunits also co-localise to the gene body of actively transcribed genes and 
enrich towards the TES, similarly to H3M36me3. Pearson’s correlation remained 
elevated when we focused on active promoter and enhancer regions (n = 52,329) 
(Fig. 7b). Both subunits displayed very similar binding pattern to each other over 
the transcription start site (TSS), gene body and transcription end site (TES) of all 
the annotated genes (Fig. 6b) and were tightly linked to H3K4me3 (Fig. 6c). 
Importantly, FACT and Chd2 (functional equivalence to yeast Chd1 (de 
Dieuleveult et al., 2016)) exhibited opposite binding distribution patterns with the 
latter strictly encompassing the whole transcription unit (Fig. 3c). This is in 
agreement with genetic results obtained in yeast, demonstrating that Chd1 and 
yFACT have opposing functions during transcriptional initiation (Biswas et al., 
2008). Our data suggest that FACT is enriched on active transcription sites and is 
mainly involved in transcriptional elongation and termination.  
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Figure 5: FACT levels are diminishing in a differentiated state. a, qPCR 
measuring Ssrp1 mRNA levels among different cell lines. FACT levels are high in 
stem (mESCs) and cancer (N2a, B16) cells and are dramatically reduced in 
differentiated cells (MEFs, NIH3T3). b, Heatmap assessing the mRNA levels (RPKM) 
of FACT (Ssrp1, Supt16) at different timepoints of differentiation of ES cells to 
cardiomyocytes (Wamstad et al., 2012) (ESC = Embryonic Stem Cells, MES = 
Mesodermal cells, CP = Cardiac Precursors, CM = Cardiomyocytes). 
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Figure 6:  FACT correlates with active gene expression. a, Scatterplot of SSRP1 and 
SUPT16 coverage over all annotated genes (n = 13,348). b, Distribution of SSRP1 
relative to the TSS (± 2000 bp) and the TES (± 2000 bp) for four different gene classes 
ranked by level of RNA abundance (High, Medium, Low, Very Low). Gene clustering 
arises from division of mRNA expression into four different quantiles. c, Same as b but 
for SUPT16. d, Scatterplot of the log2SSRP1 coverage over log2 mRNA expression. 
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Figure 7: Correlated occupancies across FACT-bound regions. a, Heatmap representing 
Pearson’s correlation between FACT subunits (SSRP1, SUPT16), and other factors over the 
gene body area of all unique annotated genes (n = 13,348). b, Same as a but for 
promoter/enhancer regions (n = 52,329)  characterised by H3K27ac and/or H3K4me1 marks. c, 
Distribution of FACT and other factors (ChIP-seq tags indicated in blue) over the TSS of 13,348 
unique RefSeq genes, sorted by H3K4me3 levels. Coinciding RNA expression levels are shown 
in red. 
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4.2 FACT modulates cell proliferation in ES cells 
 
To investigate how FACT orchestrates transcriptional regulation in ESCs, we 
depleted SSRP1 levels using different combinations of short hairpin RNAs 
(shRNA – Fig. 8a & 8b). Surprisingly, we observed an increase in mESC 
proliferation following Ssrp1 knock-down (KD) as measured by proliferation rate 
using MTT assays (Fig. 8c & 8d). However, ablation of Ssrp1 levels in a 
neuroblastoma (N2a) and a skin cancer (B16) cell line did not cause a significant 
change in the proliferation rate of cells (Fig. 9a). In yeast, Spt16 inactivation 
leads to lethality of the mutant strains (Biswas et al., 2005). Concomitant to 
higher eukaryotes, inhibition of FACT has been linked to tumour size reduction 
and diminished tumour progression (Gasparian et al., 2011; Koman et al., 2012). 
In addition, Ssrp1 -/- mouse embryos die soon after preimplantation (Cao et al., 
2003). However, increased proliferation of mESCs following FACT depletion is in 
agreement with previously published data demonstrating that deletion of Ssrp1 in 
Drosophila neuroblasts (embryonic cells giving rise to neuronal fibres) leads to 
increased proliferation of this cell type (Neumüller et al., 2011). Therefore, our 
data suggest a distinctive function of FACT in ES cells compared to cancer and 
yeast with regard to controlling cell proliferation. 
 To understand the impact of FACT ablation on the transcriptional landscape, we 
sequenced the whole transcriptome (RNA-seq). In total, we characterised 3,003 
differentially expressed genes; 1,655 down-regulated and 1,348 up-regulated 
(Fig. 8e). Down-regulated genes were over-represented for pathways involved in 
development, while up-regulated genes were involved in metabolic processes 
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and positive regulation of cell growth (Fig. 8f), indicating that FACT negatively 
controls cell proliferation in ES cells.  
In addition, Mass spectrometry analysis of whole proteome between Control and 
Ssrp1 depleted conditions, displayed a high correlation (Pearson R= 0.52) among 
mRNA and protein levels (Fig. 9b). Interestingly, the SUPT16 protein levels, but 
not the mRNA levels, decrease dramatically following depletion of Ssrp1 levels, 
suggesting that the FACT complex is functional and able to exert its function only 
when both subunits are present.  
This interdependence has also been previously reported in human cells where in 
vitro differentiation (Garcia et al., 2011) or depletion (Safina et al., 2013) of either 
subunit leads to deterioration of both subunits. In addition, they similarly report no 
change in gene expression levels of either subunit upon FACT depletion. These 
data support a model where a very stable complex is promptly disrupted in 
specific conditions (e.g. cell differentiation) when it is no longer required. 
Moreover, this inter-regulation of SSRP1 and SUPT16 levels provides a FACT 
reformation barrier that is disrupted in abnormal conditions such as cancer.  
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Figure 8: FACT controls cell proliferation and developmental pathways. a, Western 
blots after transfection of mESCs with different combinations of Ssrp1 shRNA vectors 
(shRNA 1&2). Anti-α-Tubulin was used as a reference. b, Same as a but for a different 
combination of Ssrp1 shRNA vectors (shRNA 3&4). c, MTT assay following transfection 
with Ssrp1 shRNA 1&2 vectors. Values are mean and SE of three independent 
transfection experiments are displayed. Significance was calculated via a two-tailed t-test 
(*P < 0.05). d, Same as c but for a different combination of Ssrp1 shRNA vectors 
(shRNA 3&4). e, Volcano plot of differentially expressed genes between the 
Control and KD group. Values with logFC > 1 or logFC <-1 and Adjusted P.value 
< 0.01 are highlighted in red. f, Gene ontology analysis of all differentially 
expressed genes (Red: pathways for down-regulated genes, Blue: pathways for 
up-regulated genes). 
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Figure 9: Selective function of FACT in controlling mRNA and protein levels in ES 
cells. a, MTT assay following transfection with Ssrp1 shRNA 1&2 vectors in ES, N2a, 
and B16 cells. Values are mean and SE of three independent transfection experiments 
are displayed. Significance was calculated via a two-tailed t-test. b, Scatteplot of logFC 
of mRNA and protein levels following depletion of Ssrp1. c, Heatmap displaying the 
logFC (mRNA and protein) of several genes after depletion of Ssrp1 levels. 
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4.3 FACT controls expression of active genes via nucleosome deposition 
 
Despite FACT occupancy exhibiting high correlation with active gene expression, 
depletion of FACT levels in mESCs causes an abrupt de-regulation of genes that 
are bound by it. A low correlation (Pearson’s R = 0.11) was observed between the 
coverage of SSRP1 (ChIP-seq) and the gene fold change (RNA-seq) of those genes in 
the Ssrp1 KD (Fig. 10a). Apart from down-regulated genes, we discovered a class of 
genes whose expression was not influenced by FACT depletion despite being a FACT-
target. Interestingly, a third class of FACT-bound genes emerged, which displayed high 
levels of RNA, suggesting that FACT negatively regulates the expression of these genes 
in mESCs by preventing over-expression. 
Since FACT is responsible for the remodelling of nucleosomes in the front of 
RNA polymerase and the re-establishment of nucleosome integrity in its wake 
(Formosa, 2012), we next sought to investigate the changes in the nucleosomal 
landscape triggered by the absence of FACT. MNase-resistant 
mononucleosome-sized DNA fragments (135-170 bp) were purified from control 
and Ssrp1-depleted conditions, and sequenced.  Nucleosome occupancy was 
plotted for six different gene classes according to the presence of SSRP1 in the 
control group (ChIP-seq) and their relative Fold Change in the Ssrp1 KD state 
(RNA-seq) (Fig. 10b). Genes whose expression was not impacted in the KD (“No 
change” class) displayed similar mononucleosome patterns among SSRP1 and 
Non-SSRP1 targets, implying that FACT affects neither nucleosome occupancy 
nor gene expression in this gene class. On the other hand, genes that are down-
regulated in the Ssrp1 KD (“Down-regulated” class) and bound by FACT exhibit a 
global mononucleosomal shift by a few nucleotides right after the +1 nucleosome. 
In contrast, genes which are bound by FACT and up-regulated in the Ssrp1 KD 
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(“Up-regulated” class) display two mononucleosomes in the Nucleosome Free 
Region (NFR), which are lost in the absence of FACT. In addition, the +2 and +3 
nucleosome occupancy drops in the absence of FACT. This increased 
nucleosome occupancy at the promoter region is highly reproducible among the 
different replicates and seems to arise from three distinctive gene clusters of 
diverse expression levels  (Fig. 11). In concordance to the RNA-seq data, FACT 
dampens the expression of pro-proliferative genes by regulating the positioning of 
nucleosomes in the vicinity of the TSS.  
Corroboratively, this is in agreement with data generated in S. cerevisiae where 
FACT regulates local nucleosomal stability to maintain the repression of non-
coding transcripts (Feng et al., 2016). Moreover, at the long non-coding SER3 
locus in S. cerevisiae, absence of FACT leads to loss of nucleosomes at the 
promoter, which subsequently triggers expression of the gene (Hainer, Pruneski, 
Mitchell, Monteverde, & Martens, 2011), indicating that FACT might regulate 
expression of genes indirectly through the positioning of nucleosomes. 
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Figure 10: Nucleosome deposition by FACT dampens gene expression.  a, 
Scatterplot of log (SSRP1 coverage) (ChIP-seq) over logFC (RNA-seq). b, Nucleosome 
occupancy of all genes indicated in a. Datasets are split by their FACT occupancy status 
(SSRP1 and Non-SSRP1 targets) and their relative transcriptional direction (“Down-
regulated”, “No Change”, “Up-regulated”). 
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Figure 11: Reproducibility assessment of MNase-seq dataset a, Histogram showing 
the sequenced paired-end fragments lengths extracted from Control and Ssrp1 depleted 
conditions. Fragments between 135-170 bp (indicated in red) have been computationally 
selected and used to plot mono-nucleosomal occupancy over promoter regions. 
Correlation scatterplots (MNase-seq) accessing replicate reproducibility in each 
condition. Pearson’s correlation is indicated at the top of each plot. b, Nucleosome 
occupancy metaplots for each replicate for the composite metaplot in Figure 10b. This 
nucleosome occupancy at the promoter region derives from three distinctive gene 
clusters of diverse gene expression. 
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4.4 FACT and chromatin remodellers control gene expression 
 
Next, we wanted to determine whether there are factors that are decisive in 
determining if a gene changes its expression level upon depletion of FACT. We 
turned to nucleosome remodellers, and examined their distribution around the 
TSS of all three gene classes (SSRP1 targets). No change was observed in 
occupancy for Chd1, Chd2, or Chd4, but we detected a striking difference in 
Ep400, Smarcad1, and Chd6/8/9 (Fig. 12). This implicates that changes in the 
presence and occupancy degree of the latter ones are decisive for transcriptional 
activity upon depletion of FACT levels. 
The presence of FACT elicits a tight co-ordination of transcription over H3K4me3 
and bivalent (H3K4me3 and H3K27me3) promoters. In a highly bivalent state, 
Ep400, Chd6, and Chd8 bind exclusively to the -1 nucleosome upstream of the 
TSS. We hypothesize that in the absence of FACT, recruitment of the SWI/SNF 
complex occurs over certain promoter regions and further represses expression 
of those lineage-specific genes (Wilson & Roberts, 2011). This speculation is 
reinforced by the fact that we observe a nucleosomal shift in the “Down-
regulated” class (Ssrp1 KD); a mechanistic feature that has been previously 
reported to be driven by SWI/SNF (Nocetti & Whitehouse, 2016). In highly active 
genes (H3K4me3) both the +1 and -1 nucleosomes are engaged by Ep400, 
Chd6, and Chd8. In addition, our data suggest that promoters that are occupied 
by FACT, enable Set1 binding further downstream of the TSS which 
subsequently allows broad H3K4me3 and Pol II distribution. Other remodellers 
might bind as well but their function and contribution to transcriptional regulation 
remains unclear.  
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Nevertheless, the presence of Chd9 on the +1 nucleosome seems to play an 
essential part in the transcriptional decision between “Up-regulation” and “No-
change” when FACT is absent. Loss of FACT probably allows Chd9 to re-order 
chromatin and facilitate binding of TFs that will subsequently allow increased 
downstream mRNA production. Expression of Chd9 has been previously shown 
to display a critical role in cellular differentiation and bone growth (Marom, Shur, 
Hager, & Benayahu, 2006), whereas more recently a link between Chd9 and 
ribosomal transcription has been reported (Salomon-Kent et al., 2015). 
Considering that the high H3K4me3 “Up-regulated” class exhibits elevated 
occupancy of Chd9 on the +1 nucleosome, we hypothesise that Chd9 
reorganises chromatin and allows binding of GTFs in the absence of FACT. 
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Figure 12:  Distribution of different nucleosome remodellers over the TSS of FACT-
bound promoters. Datasets are split by their relative chromatin (H3K4me3 High, 
H3K4me3 Low) and gene expression status (“Down-regulated”, “No-Change”, “Up-
regulated”). Model of how FACT and chromatin remodellers might regulate 
transcriptional directionality over lowly (1
st
 model) and highly (2
nd
 model) expressed 
promoters. The whole model was derived by comparing the H3K4me3 High class 
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between the “Up-regulated” (High expression) and “Down-regulated” (Low expression) 
gene clusters. In the 1
st
 model, the presence of FACT will obstruct binding of the 
SWI/SNF complex (Fig. 19c-Smarcad1) to prevent down-regulation of lineage-specific 
genes. Moreover, global nucleosomal shifting after the +2 nucleosome will be avoided. In 
the 2
nd
 model, the presence of FACT enables binding of Set1 and ultimately 
establishment of a broad H3K4me3 mark. In addition, the Ep400-Chd6-Chd8-Chd9 
complex in the +1 nucleosome probably marks those promoters for up-regulation in the 
absence of FACT. 
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4.5  Nucleosome deposition affects RNA pol II pausing index 
 
Over the last decade it has become apparent that promoter proximal pausing of 
RNA Pol II plays an important role in regulating gene expression (I Jonkers & Lis, 
2015). To explicate the interplay between the Pol II – FACT complex and RNA 
Pol II transcription, we performed NET-seq (Mayer et al., 2015) to identify 
transcribing RNA Pol II over SSRP1- and Non-SSRP1-bound  regions. A higher 
correlation and a significantly higher slope of nascent RNA – mRNA expression 
was observed over the SSRP1-bound regions in both the Control and the Ssrp1 
KD state (Fig. 13a,b) suggesting diverse elongation rates of Pol II in the absence 
of FACT. To confirm this, we measured the travelling ratio of Pol II over the three 
different gene classes (“Down-regulated”, “No Change”, and “Up-regulated”). 
Compared to the Non-SSRP1 target regions, SSRP1-bound regions whose 
expression is either down-regulated or not changed, did not display a significant 
difference in the Pol II pausing index (Fig. 13c). Nevertheless, genes that were 
upregulated in the absence of FACT exhibited, in the Control state, a lower 
pausing index compared to their Non-SSRP1 target counterparts. However, this 
difference was preserved in the absence of FACT, indicating that FACT has no 
effect on the release of paused Pol II and its successful progression towards 
transcriptional elongation. Given the differences in Pol II S2 density profiles 
(ChIP-seq- Fig. 13c) and promoter architecture as defined by MNase-seq (Fig. 
10b), it is tempting to speculate that genes upregulated by knock-down of FACT 
undergo a different pausing mechanism. 
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Figure 13: Pol II elongation rate is altered in the absence of FACT.  a, Scatterplots of 
log gene body coverage (NET-seq) versus log mRNA expression (RNA-seq) for SSRP1 
(n=4,576) and Non-SSRP1 (n=8,844) target regions in the Control (Z-score = 5.3, P < 
10-5) and Ssrp1 KD (Z-score = 7.2, P < 10-5)  state. b, Measure of Pol II pausing. 
Travelling ratio is defined as NET-seq density of proximal promoter versus gene body 
area. Normalised travelling ratios for each gene class are displayed as boxplots. 
Densities in each condition have been normalised to “Up-regulated / Non-SSRP1 
targets”. The Wilcoxon rank test was used to calculate significance between SSRP1 and 
Non-SSRP1 targets. c, Distribution of elongating Pol II variant (S2 ph – WT ES cells) 
over the TSS (± 2000 bp) of SSRP1- and Non-SSRP1-bound regions split by 
transcriptional regulation (“Up-regulated”, “No Change”, “Down-regulated”). The “Up-
regulated” SSRP1-bound gene class exhibits a different occupancy pattern. 
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4.6 Pol II density anti-correlates with nucleosome density 
 
To further explicate the impact of nucleosome occupancy on Pol II density, we 
initially interrogated the nuclesomal landscape over CTCF and H3K27Ac regions. 
The reason behind this is the fact that we employed a different MNase-seq 
protocol that only retains soluble chromatin and thus avoids calculation of biases 
arising from formaldehyde cross-linking. We split the data to either small (< 80 
bp) or larger (135-170 bp) fragments corresponding to transcription factor 
footprints and mono-nucleosomes, respectively. Nucleosomal occupancy over 
CTCF and H3K27Ac regions seems to be identical to previous reports (Carone et 
al., 2014; Teif et al., 2012), further reinforcing the legitimacy of our data (Fig 14 
a,b). We next sought to determine nucleosomal distribution over all exonic 
regions. Data obtained from insoluble chromatin suggest that nucleosome 
occupancy in the intronic regions is higher compared to the exons, as opposed to 
the soluble chromatin where the opposite effect is observed (Fig 14 c). Our 
MNase-seq findings are corroborative to the soluble chromatin pattern (Fig. 14 d) 
and anti-correlate with Pol II pausing (Fig. 14 e). Increased mono-nucleosome 
occupancy of exons in the Ssrp1 KD state negatively affects Pol II pausing over 
those regions. Therefore, our data suggest that the presence of nucleosomes 
influences to some extent pausing of Pol II over splice sites as well as over the 
whole exonic region.  
In addition, our MNase-seq data are not in agreement with previous reports 
stating  that nucleosomal occupancy of exons is higher compared to introns 
(Tilgner et al., 2009). We followed an MNase treatment protocol that gets rid of 
insoluble chromatin and retains soluble nucleosomes that are not bound by 
proteins/ transcription factors. This allows a direct interrogation of the soluble 
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nucleosomal landscape and makes it ideal for studying proteins involved in 
chromatin/ nucleosome remodelling. Higher intronic nucleosome occupancy can 
also be observed in other published data where soluble chromatin has been 
extracted (Carone et al., 2014). In addition, chemical mapping of nucleosomes 
also supports a lower occupancy of nucleosomes over exonic regions (Voong et 
al., 2016). Nevertheless, the ingenuity of our results can be further supported by 
the nucleosomal distribution adjacent to CTCF and H3K27Ac binding sites which 
is identical to other MNase-seq profiles obtained both from soluble and insoluble 
chromatin (Carone et al., 2014; Teif et al., 2012).  
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Figure 14: Quality control assessing MNase-seq/ NET-seq  integrity. a, CTCF peak 
midpoints were used as a reference and nucleosome occupancy for short (<80 bp) and 
long (135-170 bp) MNase footprints was plotted over the TSS. b, Same as a but for 
H3K27Ac. Both CTCF and H3K27Ac profiles are consistent with previous 
studies(Carone et al., 2014; Teif et al., 2012). c, MNase-seq datasets of soluble (higher 
intron occupancy) and insoluble (higher exon occupancy) chromatin retrieved from 
Carone et al. d, Mean nucleosomal density (207,232 exons) of our insoluble MNase-seq 
dataset. The soluble nucleosome profile in “c” is highly consistent to our MNase treated 
samples for both conditions where nucleosomal occupancy on introns is similar or higher 
compared to the exons.  Identical occupancy is also observed by chemical mapping of 
nucleosomes (Voong et al., 2016). e. NET-seq heatmaps and density plots over 41,356 
exons with the highest Pol II coverage. Solid lines on the NET-seq meta-exon plots 
indicate the mean values, whereas the shading represents the 95% confidence interval. 
Density around the 3’SS and 5’SS was scaled independently. Pol II occupancy over 
exonic regions is higher compared to introns as opposed to nucleosome occupancy. 
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4.7  FACT enables broad distribution of H3K4me3 
 
Taken into consideration the unanticipated MNase-resistance over the NFR 
region of the “Up-regulated” class in the control group, we sought to understand 
how chromatin modifications localise across the promoter regions of this class of 
genes. We compared regions that were characterised either by high or low levels 
of H3K4me3 (Fig. 15a). Intriguingly, we observed that the SSRP1-bound, high 
H3K4me3 regions exhibit a broad distribution of the chromatin mark; a result 
consistent with Set1 (responsible for H3K4me3 establishment) distribution over 
the TSS of the above genes. Set1 is recruited to the 5’ ends of genes by the Pol 
II S5ph variant while establishment of H3K4me3 enables Pol II elongation (Hsin & 
Manley, 2012). No broad H3K4me3 distributions were observed in the “No 
Change” or the “Down-regulated” gene classes (Fig. 15 b,c), with the latter being 
characterised by low gene expression and high enrichment of H3K27me3. Broad 
H3K4me3 domains have been previously linked before to cell identity and 
increased transcriptional elongation (Benayoun et al., 2014; Chen et al., 2015; 
Liu et al., 2016). Therefore, we focused more on the high H3K4me3 class of 
genes in the “Up-regulated” class in order to understand the consequences of 
directionality. Intriguingly, key pluripotency factors (e.g. Oct4,Sox2, Nanog, and 
Klf4) belong to this gene cluster. 
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Figure 15: FACT enables broad 
distribution of H3K4me3 via Set1 binding. 
Occupancy heatmaps and profiles  for 
H3K4me3, H3K27me3, and Set1 in the “Up-
regulated” (a), “No Change” (b), and “Down-
regulated” (c) class. Datasets are split by 
chromatin (H3K4me3 and Bivalent) and 
FACT binding status (SSRP1 and Non-
SSRP1 targets) in WT mESCs. Occupancy 
was plotted relative to the TSS ± 2000 bp. 
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4.8 FACT restricts divergent Pol II via nucleosome deposition 
 
H3K4me3 serves as a recruitment platform for TFs and RNA Pol II (Sims et al., 
2007). Strikingly, NET-seq density plots identified that SSRP1 targets displayed 
high levels of promoter proximal pausing of RNA Pol II at the TSS, but also a 
strong and wide Pol II distribution similar to the H3K4me3 mark with little signal of 
divergent Pol II in the anti-sense strand (Fig. 16- H3K4me3 High- SSRP1 
targets). The broad distribution in the sense strand was also confirmed by 
employing published GRO-seq data (Fig. 17). On the other hand, non-SSRP1 
target regions exhibited an equal distribution both in convergent and divergent 
Pol II (H3K4me3 High- Non-SSRP1 targets – Fig. 17).  Upon knock-down of 
FACT, SSRP1 targets display higher levels of convergent transcription, and even 
more strikingly, a strong increase (P < 10-27 and P < 10-20) in divergent 
transcription compared to the Non-SSRP1 targets. To understand how FACT 
inhibits divergent transcription, we examined nucleosomal distribution over these 
promoters. Both high and low H3K4me3 genes, targeted by FACT, exhibited 
significantly increased levels of nucleosome occupancy (P < 10-18 and P < 10-4) 
upstream of the TSS, as opposed to the non-bound counterparts. Upon FACT 
depletion, nucleosome occupancy is decreased upstream of the TSS (P < 10-8, P 
< 10-6), resulting in a more open chromatin conformation and bi-directional 
travelling of Pol II. 
Moreover, this increase in antisense transcription and loss of nucleosome 
occupancy is observed only in genes that are up-regulated upon FACT depletion 
(Fig. 16 & Fig. 17 a,b). These observations suggest that SSRP1-bound 
promoters construct directionality and inhibit divergent transcription by providing 
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a high level nucleosome barrier at the -1 and -2 nucleosomes. Such a scenario 
would be in agreement with data generated in S. cerevisiae where FACT 
regulates local nucleosomal stability to maintain the repression of non-coding 
transcripts(Feng et al., 2016). Taken together, FACT regulates unidirectional 
passage of RNA Pol II via nucleosome positioning.  
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Figure 16: FACT restricts divergent transcription via nucleosome deposition in the 
NFR.  NET-seq and nucleosome occupancy plots (Control and Ssrp1 KD group) split by 
chromatin and FACT-bound status. Solid lines on the MNase-seq and NET-seq 
metaplots indicate the mean values, whereas the shading represents either the SE of the 
mean (MNase-seq) or the 95% confidence interval (NET-seq). Significant changes in Pol 
II/ nucleosome density were calculated using a Wilcoxon rank test. 
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Figure 17: FACT enables broad distribution of RNA pol II over high H3K4me3 
promoters.  a, NET-seq density plots for the “No Change” class split by FACT binding 
status (SSRP1 and Non-Ssrp1 targets) and condition (Control and Ssrp1 KD). 
Occupancy was calculated relative to the TSS ± 2000 bp. b, Same as a but for the 
“Down-regulated” class. c, GRO-seq density plots derived from WT mESCs for the three 
different gene classes split by FACT binding status (SSRP1 and Non-Ssrp1 targets). 
Solid lines on the NET-seq and GRO-seq metaplots indicate the mean values, whereas 
the shading represents the 95% confidence interval. 
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Next, we focused on a single gene level to confirm whether nucleosome 
occupancy in the NFR hinders divergent transcription over FACT-bound 
promoters. Indeed, NET-seq antisense density seems to transit from convergent 
to divergent following depletion of Ssrp1 mRNA levels, concomitantly with 
nucleosomal loss in the NFR (Oct4 – SSRP1 target). On the contrary, Psmb6 
(Non-SSRP1 target) exhibits a slight increase of sense and anti-sense 
transcription in the Ssrp1 KD state without a significant change in nucleosome 
density. The above data suggest that FACT regulates unidirectional passage of 
RNA Pol II via nucleosome positioning (Fig. 18). 
 
 
 
Figure 18: Nucleosomal loss at the NFR instigates divergent transcription. 
Transcriptional activity (NET-seq) and nucleosome occupancy (MNase-seq) of SSRP1 
(Oct4) and non-SSRP1 (Psmb6) targets between Control and KD group. Nucleosomal 
loss in Oct4  is indicated by a red-dotted line 
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4.9 FACT facilitates the alternative splicing of mRNA transcripts 
 
High levels of H3K4me3 that span the first exon of the coding sequence have 
been implicated in efficient transcription (Bieberstein, Oesterreich, Straube, & 
Neugebauer, 2012). One potential explanation for this is that short exons are 
important for the precise recruitment of general transcription factors (GTFs). To 
further understand how FACT recruitment regulates gene expression, we 
examined the distribution of H3K4me3 and FACT over the first exon of all genes. 
Both H3K4me3 and FACT show high similarity in occupancy over the first exon, 
with the medium exon length class (> 250 and < 750 bp) displaying the highest 
occupancy over the first exon-intron junction (Fig. 19 a,b). 
 To determine the compendium of factors associating with FACT on actively 
transcribed regions, we performed an Immunoprecipitation (IP) for H3K4me3 
followed by mass spectrometry between the Control and Ssrp1 KD group. GTFs, 
cell cycle, and DNA proliferation components (MCM helicase complex) exhibited 
a significantly increased recruitment to H3K4me3 in the absence of FACT. 
Association of MCM and FACT has been previously reported in a cell cycle-
dependent matter (Tan, Liu, Lin, & Lee, 2010), thus potentially explaining the 
increased cell proliferation we observed following depletion of FACT levels. 
Components of the spliceosome (e.g. CWC15, U2AF1) and several splicing 
factors (e.g. RBM17, SF3B6) displayed significantly decreased recruitment on 
H3K4me3 in the Ssrp1 KD (Fig. 19 c). Interestingly, recruitment of components 
of the core spliceosome on H3K4me3 has been reported before in datasets using 
either peptides (Vermeulen et al., 2010) or modified nucleosomes (Bartke et al., 
2010).  
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We thus speculated about a potential involvement of FACT in alternative splicing. 
In total, we identified 356 Exon skipping/inclusion and 97 Intronic retention events 
in the KD group (Fig. 20  a,b,c).  Yeast spt16 mutant strains have been shown 
before to retain intronic regions as a result of a compromised splicing machinery 
(Burckin et al., 2005). Skipped and retained exons were split according to exon 
length (< 500 bp and > 500 bp) and FACT-bound status (SSRP1 and Non-
SSRP1 targets). Remarkably, the SSRP1-bound skipped exons exhibit lower 
length size in the alternative spliced “Long-exons” category (Fig. 20 d) compared 
to their non-bound counterparts (P = 0.02, Kolmogorov–Smirnov test), indicating 
an explicit facilitation of splicing for longer exons when FACT is present. 
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 Figure 19: FACT along with H3K4me3 serve as a protein docking site. a, Average 
distribution of SSRP1 and H3K4me3 aligned to the 5' Splice Site (5'SS) of all genes 
grouped by first exon length. b, Same as a but for SUPT16, c, Volcano plot of 
depleted/enriched proteins at H3K4me3 following Ssrp1 KD.  
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4.10 FACT is involved in the alternative splicing of gene isoforms 
 
As differential exon-intron GC content and nucleosome occupancy are 
associated with exonic splicing (Amit et al., 2012; Kornblihtt et al., 2013; Sibley et 
al., 2016) ,we next sought to identify whether differential nucleosome occupancy 
between the control and the Ssrp1 KD group is pivotal for alternative exon usage. 
We categorised the data according to the relevant exon skipping/ inclusion event 
(Fig. 20 a).  
Altered nucleosome distribution can affect alternative exon usage (Iannone et al., 
2015; Kornblihtt, Schor, Allo, & Blencowe, 2009). Hence, we interrogated 
nucleosomal distribution over 3’ and 5’ Splice Sites (SS). No significant difference 
was observed among the two conditions perhaps due to the presence of gene 
isoforms that encode different alternatively spliced exons. Nevertheless, we also 
determined RNA Pol II density derived from NET-seq data as this monitors the 
pausing degree at a single nucleotide resolution over splice sites (Mayer et al., 
2015). Similarly to the MNase-seq data, no significant changes were observed 
among the two conditions due to low read density (Fig. 21). 
Despite NET-seq being a powerful technique in determining the position of Pol II 
genome-wide at a single nucleotide resolution, the library preparation steps are 
characterised by a substantial loss of genomic material that causes the 
emergence of numerous PCR duplicates in the final product (Mayer & 
Churchman, 2016). Although, here we present an improved version of NET-seq, 
future work should focus on optimally adjusting the library preparation with regard 
to maximising Pol II coverage. 
 
Results & Discussion 
 
74 
 
 
 
 
 
Results & Discussion 
 
75 
 
Figure 20: FACT facilitates alternative splicing of RNA transcripts. a, Average 
distribution of SSRP1, SUPT16, and H3K4me3 aligned to the 5' Splice Site (5'SS) of all 
genes grouped by first exon length. b, Volcano plot of depleted/enriched proteins at 
H3K4me3 following Ssrp1 KD. c, Barplots representing the number of included/skipped 
exons categorized by their gene expression status (red: “Down-regulated”, cyan: “No 
change”, blue: “Up-regulated”). In total, we have identified 149 included and 207 skipped 
exon events in the Ssrp1 KD group. d, Graphical representation of an intronic retention 
event (Men1) in the KD group. Also, analysis of intron inclusion events or isoform 
switches after FACT depletion. Unspliced transcript percentage was measured according 
to band intensity. e, Gene ontology analysis of transcripts (FACT-bound) that display 
alternative exon usage between the two conditions. 
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Figure 21: Nucleosomal occupancy along with Pol II density drive alternative exon 
usage. Nucleosome occupancy and NET-seq density of FACT-bound exons that are 
differentially spliced upon depletion of Ssrp1. Solid lines on the NET-seq meta-exon plots 
indicate the mean values, whereas the shading represents the 95% confidence interval.  
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4.11 ES cells differentiate more efficiently into the neuronal lineage upon 
FACT depletion 
 
A fraction of the differential gene isoforms generated in the KD group is over-
represented in limbic system and dendrite development pathways (Fig. 20e). To 
confirm this, we induced ES cell differentiation towards a neuronal lineage via 
embryoid body formation and treatment with retinoic acid (Bibel, Richter, Lacroix, 
& Barde, 2007). We created early stage Neural Precursor Cells (NPCs – 3 days 
into the differentiation process) that express key neurogenesis markers (Pax6, 
Nes, Tubb3) but still maintain FACT and key pluripotency factors at a high level 
(Fig. 22a). A quarter of the up-regulated genes in ES cells after Ssrp1 KD 
overlaps with the up-regulated genes instigated by neuronal differentiation (P < 
10-13, Fisher’s exact test; Fig. 22b) and are over-represented in pathways 
involved in neuronal development. We then split these over-lapping genes 
according to FACT-bound status and interrogated nucleosome/ Pol II occupancy. 
Interestingly, all the neurogenesis-associated genes (based on gene ontology 
enrichment) found on this list are bound by FACT (n=38). Intriguingly, only these 
genes bound by FACT show a significant increase (P < 10-15) in divergent anti-
sense transcription concomitantly with loss of a nucleosomal impediment (P < 10-
46) (Fig. 22c). Up-regulation of FACT-bound genes in its absence coincides with 
a loss of nucleosome upstream of the TSS and an increase in antisense 
transcription. To test if de-repression of silenced genes in the absence of FACT 
follows a similar mechanism, we analysed nucleosome occupancy and RNA Pol 
II profiles over these genes. The observed changes in nucleosome and RNA Pol 
II occupancy were even more pronounced in this gene class, and exhibited 
similar patterns (Fig. 23). Divergent transcription has been suggested to enhance 
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transcription by opening up promoters and allowing binding of multiple 
transcription factors (Scruggs et al., 2015).  
Finally, to understand the biological impact of FACT depletion on neuronal 
development, we depleted Ssrp1 levels at the onset of neuronal differentiation 
and performed immunofluorescence for neurogenesis (β3-Tubulin) and dendritic 
(MAP2) markers at the same time point as the RNA-seq experiment. SSRP1 KD 
caused a substantial increase in the expression of those markers, indicating that 
loss of FACT function primes ES cells for the neuronal lineage and enhances 
early neuronal differentiation (Fig. 22d).   
Based on a genome-wide RNAi screen in Drosophila, Ssrp1 was discovered as a 
gene that will lead to hyper-proliferation of neuroblasts (Neumüller et al., 2011) – 
a neuronally committed cell type. Usually, neuroblasts divide asymmetrically at 
every stage, creating one cell that continues being a neuroblast, and one cell that 
becomes the Ganglion Mother Cell, which goes on to divide into neurons and glia 
cells (Brand & Livesey, 2011). Depletion of FACT shifts this balance and leads to 
more neuroblasts in expense of neurons. A comparison of expression patterns in 
the early developing mouse brain identified a set of only 13 genes, including 
Ssrp1 with high correlation of expression in the proliferating cells of the VZ of the 
neocortex at early stages of development (Vied et al., 2014). This is a 
transient embryonic layer of tissue containing neural stem cells (Rakic, 2009) and 
a place for neurogenesis during development dependent on the Notch pathway 
(Rash, Lim, Breunig, & Vaccarino, 2011). Our data demonstrates that FACT-
depleted ES cells differentiate much more efficiently into early neuronal 
precursors. Taken together, the data suggest an important role for FACT activity 
during neuronal differentiation and the proper levels of FACT might assist in 
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balancing proliferation speed and timing of differentiation processes. Another 
transcriptional elongation complex that interacts with FACT and was shown to 
lead to hyper-proliferation of Drosophila neuroblasts is the Paf1 complex 
(Neumüller et al., 2011). Interestingly, depletion of the Paf1 complex in mouse ES 
cells leads to a different transcriptional outcome than FACT depletion. Paf1 
down-regulation leads to loss of pluripotency, in part through down-regulation of 
the key pluripotency factors, including Nanog, Oct4, and Sox2 (Ding et al., 2009). 
Like FACT, the Paf1 complex can work as an activator and repressor of gene 
transcription in ES cells, leading to deregulation of around 1200 genes. This 
comparison between the FACT and Paf1-complex suggest that transcriptional 
regulators that impact the ES cell transcriptome in different ways can have similar 
roles during differentiation processes. 
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Figure 22: FACT regulates neurogenesis through Pol II / nucleosome dynamics. a, 
MA plot following depicting differential expression in NPCs versus WT ES cells. Up-
regulated genes are highlighted in blue whereas down-regulated genes are highlighted in 
red. b, Venn diagram showing the overlap of up-regulated genes between NPC vs 
mESCs and Control vs Ssrp1 KD mESCs. c, NET-seq and nucleosome occupancy plots 
(Control and Ssrp1 KD group) split by chromatin and FACT-bound status. Solid lines on 
the MNase-seq and NET-seq metaplots indicate the mean values, whereas the shading 
represents either the SE of the mean (MNase-seq) or the 95% confidence interval (NET-
seq). Significant changes in Pol II/ nucleosome density were calculated using a Wilcoxon 
rank test. d, Immunofluorescence (IF) analysis of early stage NPCs following Ssrp1 
depletion. (Blue) DAPI, nuclei; (Green) β3-Tubulin, neurons; (Red) MAP2, dendrites.  
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Figure 23: Distribution of chromatin marks, nucleosomes, and Pol II over lowly 
expressed/ repressed genes. a, Occupancy heatmaps and profiles (Figure 11b– Class 
3) for H3K4me3, H3K27me3, and Set1 split by chromatin (High H3K4me3 and Low 
H3K4me3) and FACT binding status (SSRP1 and Non-Ssrp1 targets). Occupancy was 
calculated relative to the TSS ± 2000 bp. b, NET-seq and nucleosome occupancy plots 
(Control and Ssrp1 KD group) split by chromatin and FACT-bound status. Solid lines on 
the MNase-seq and NET-seq metaplots indicate the mean values, whereas the shading 
represents either the SE of the mean (MNase-seq) or the 95% confidence interval (NET-
seq). Significant changes in Pol II/ nucleosome density were calculated using a Wilcoxon 
rank test.  
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5 Conclusion and Outlook 
 
As described above, the presented study has contributed in elucidating the 
molecular mechanisms under which FACT maintains pluripotency and governing 
of RNA Pol II in vivo. We have applied a wide range of sequencing and 
proteomics experiments (ChIP-seq, RNA-seq, MNase-seq, NET-seq, and Mass 
spectrometry) to fully characterise the interplay between FACT, nucleosomes, 
RNA Pol II, and chromatin dynamics. Our main findings are; 
 FACT is involved in transcriptional elongation and is tightly linked to active 
gene expression. In addition, we have characterised FACT as both an 
activator and repressor of transcription.  
 FACT ablation leads to little changes in nucleosome occupancy genome-
wide. In fact, it seems to regulate expression of a specific class of genes 
involved in embryonic development (e.g. Yamanaka factors) by placing 
nucleosomes upstream of the TSS and hence maintaining a closed 
chromatin conformation state. 
 FACT represses specifically genes involved in neurogenesis. Its depletion 
primes neural precursor formation by activation and alternative splicing of 
the above genes. 
 This nucleosome deposition upstream of the TSS hinders divergent 
travelling of Pol II. 
  FACT and several nucleosome remodellers control gene expression 
whereas the occupancy degree of the later ones seems to predict the 
change in gene expression levels in the absence of FACT. 
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Taken together, FACT maintains pluripotency through nucleosome deposition 
and Pol II governing. 
 
 
Figure 24: Model of the suppressive role of FACT in gene expression and 
maintenance of pluripotency. Upper; FACT places a nucleosomal barrier at the 
promoter region of genes involved in embryogenesis/ neurogenesis that hinders 
divergent travelling of Pol II and enables a closed chromatin conformation state. Lower; 
In the absence of FACT, the nucleosomal barrier is alleviated, thus allowing bi-directional 
travelling of Pol II, recruitment of GTFs, increased gene expression, and ultimately, 
activation of neurogenesis cues. 
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We have confirmed FACT’s involvement in transcriptional elongation. However, 
we have discovered that FACT is not contributing to the release of initiating Pol II 
to a successive elongation like NELF and P-TEFb. Since FACT binds also 
upstream of the TSS, could it also be involved in transcriptional initiation and 
assembly of the pre-initiation complex (PIC)?  
To address this question we would require interrogation of FACT occupancy and 
of other initiation complexes using more sophisticated/high resolution mapping 
approaches (ChIP-exo/ ChIP-nexus - (Shao & Zeitlinger, 2017)) followed by 
chemical inhibition of transcriptional elongation.  
Moreover, recent reports have shown that Pol II variants display different binding 
on nascent RNA as opposed to genomic DNA (Nojima et al., 2015). Could this be 
the same for FACT as well as for other elongation factors? Is there perhaps an 
intrinsic function for FACT that allows dynamic phosphorylation of Pol II as it 
synthesizes newly formed RNA? More specific and directed techniques would be 
required to be developed to structurally interrogate co-binding of FACT and Pol II 
during nascent RNA synthesis.  
 
 
 
  
Materials 
 
87 
 
6 Materials  
 
Growth media and antibiotics 
 
DMEM + GlutaMax Gibco 
Fetal Bovine Serum (FBS) Gibco 
MEM non- essential amino acids Gibco 
Penicillin/ Streptomycin Gibco 
2-mercaptoethanol Gibco 
Leukaemia Inhibitory Factor (LIF) eBioscience 
Retinoic Acid (RA) Sigma 
Puromycin Sigma 
 
 
Buffers 
ChIP-seq Cell Lysis Buffer 
 
5 mM Tris  
pH8.0, 85 mM KCl 
0.5% NP40 
 
 Nuclei Lysis Buffer 
 
1% SDS 
10 mM EDTA 
50 mM Tris HCl 
 
 IP buffer 
 
0.01% SDS 
1.1% Triton-X-100 
1.2 mM EDTA 
16.7 mM Tris HCl, 
67 mM NaCl 
 
 TSE -150 
 
1% Triton-X-100 
0.1% SDS 
 2 mM EDTA 
20 mM Tris HCl 
150 mM NaCl 
 
 TSE -500 
 
1% Triton-X-100 
 0.1% SDS 
2 mM EDTA 
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20 mM Tris HCl 
500 mM NaCl 
 
 LiCl buffer 
 
0.25 M LiCl 
1% NP-40 
1% dioxycholate 
1mM EDTA 
10 mM Tris HCl 
 
 Elution Buffer 1% SDS 
0.1 M NaHCO3  
 
NET-seq Cytoplasmic lysis buffer 0.15% (vol/vol) NP-40          
10 mM Tris-HCl (pH 7.0) 
150 mM NaCl 
1× protease inhibitor mix (50×) 
25 μM α-amanitin 
10 U SUPERase 
RNase-free H2O 
 
 Sucrose buffer 50% (wt/vol) filter-sterilized sucrose 
10 mM Tris-HCl (pH 7.0) 
150 mM NaCl 
1× protease inhibitor mix (50×) 
25 μM α-amanitin 
20 U SUPERase 
RNase-free H2O 
 
 Nuclei wash buffer 1 mM EDTA  
0.1% (vol/vol) Triton X-100 
1× protease inhibitor mix (50×) 
25 μM α-amanitin 
40 U SUPERase 
PBS 
 
 Glycerol buffer  20 mM Tris-HCl (pH 8.0) 
75 mM NaCl 
0.5 mM EDTA 
100% (vol/vol) filter-sterilized glycerol 
0.85 mM filter sterilized DTT 
1× protease inhibitor mix (50×) 
25 μM α-amanitin 
10 U SUPERase 
RNase-free H2O 
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 Nuclei lysis buffer  1% (vol/vol) NP-40          
20 mM HEPES (pH 7.5) 
0.1 M EDTA 
300 mM NaCl 
10 M filter sterilized urea 
1 mM filter-sterilized DTT 
1× protease inhibitor mix (50×) 
25 μM α-amanitin 
10 U SUPERase 
RNase-free H2O 
 
 Chromatin resuspension 
solution 
1× protease inhibitor mix (50×) 
25 μM α-amanitin 
20 U SUPERase 
PBS 
 
 Bind / wash buffer 5 mM Tris-HCl (pH 7.0),  
2 M NaCl 
1 mM EDTA  
0.2% (vol/vol) Triton X-100 
RNase-free H2O 
 
 
 
NET-seq reagents 
- α-Amanitin (Sigma) 
- TBE buffer, 10× (Life Technologies, cat. no. 15581-044) 
- Urea, (Sigma-Aldrich, cat. no. U6504) 
- Sodium carbonate anhydrous, proteomics grade (VWR, cat. no. M138)  
- Sodium bicarbonate (VWR, cat. no. 3509) 
- Sodium acetate, RNase-free (3 M; Life Technologies, cat. no. AM9740)  
- NaCl, RNase-free (5 M; Life Technologies, cat. no. AM9760G)  
- EDTA, RNase-free (0.5 M; Life Technologies, cat. no. AM9260G) 
- Tris-HCl, RNase-free (1 M, pH 7.0; Life Technologies, cat. no. AM9850G)  
- Tris-HCl, RNase-free (1 M, pH 8.0; Life Technologies, cat. no. AM9855G) 
- NaOH solution (1.0 N; Sigma-Aldrich, cat. no. S2770) 
- HCl, hydrochloric acid concentrate (Sigma-Aldrich, cat. no. 38282) 
- SUPERase.In (Life Technologies, AM2696) 
- Protease inhibitor mix cOmplete, EDTA-free (Roche, 11873580001) 
- Benzonase nuclease (Sigma-Aldrich, cat. no. E1014) 
 
 miRNeasy mini kit (50; Qiagen, cat. no. 217004) 
 T4 RNA ligase 2, truncated (NEB, cat. no. M0242S) 
 SYBR Gold nucleic acid gel stain (10,000× concentrate; Life Technologies, cat. 
no. S-11494) 
 RNA control ladder (0.1–2 kb; Life Technologies, cat. no. 15623-100) 
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 DNA control ladder (10 bp; Life Technologies, cat. no. 10821-015) 
 TBE-urea (TBU) denaturing sample buffer, 2× (Life Technologies, cat. no. 
LC6876) 
 SuperScript III first-strand synthesis system (Life Technologies, cat. no. 18080-
051) 
 CircLigase ssDNA ligase; (Biozym, cat. no. CL4111K) 
 Saline–sodium citrate (SSC), 20× (Life Technologies, cat. no. AM9763) 
 Phusion high-fidelity (HF) DNA polymerase (2,000 U/ml; NEB, cat. no. M0530S) 
 
 TBE-urea gels, 15% (wt/vol) (Life Technologies, cat. no. EC68852BOX)  
 TBE-urea gels, 10% (wt/vol) (Life Technologies, cat. no. EC68752BOX)  
 TBE gels, 8% (wt/vol) (Life Technologies, cat. no. EC62152BOX)  
 Mini-Cell polyacrylamide gel box, XCell SureLock (Life Technologies, cat. no. 
EI0001)  
 Black gel box (LI-COR, cat. no. 929-97301)  
 
 
NET-seq depletion oligos 
Symbol Transcript DNA sequence (5'-3') 
Snord49a snoRNA AGTCAGCCAGGAGCAGTTATCGTCAGTTATCGAC 
Rn45s rRNA GAGAGCCGCCCGAACGACCGACTTCCCTACGGGCCC 
Snord65 snoRNA CTTCAGAAAACCATAGGCTCACCACTACCAATCT 
Snord82 snoRNA GAACCATGGGGTTGAAATGAAATATGCTGATGTGCT 
Snord49b snoRNA GTCAGCTAACTAGGGATGTCGTCAGTTGTCGCAT 
Snord2 snoRNA AGTGATCAGCAAGAGTATTCTCTTCATTTCAGGTCA 
Snord99 snoRNA TCTCAGTCCCATATCCGCATTTCTCATCCATAGA 
Snord95 snoRNA CAGCTCAGAAACAGCCTCTGGATTTCAGCAAAGCAA 
Snord55 snoRNA CGTGGGGAAGCCAACCTTGGAGAGCTGAGCGTGC 
Snord68 snoRNA CATCAGATGGAAAAGGGTTCAAAAGTACTTTCAT 
Snord32a snoRNA GACTGTGAGATCAACCCATGCACCGCTCTGAGACTC 
Snord87 snoRNA GTTTCTTTGAAGAGAGAATCTTAAAAGACTGAGA 
Rmrp ncRNA CGCACCAACCACACGGGGCTCATTCTCAGCGCGGCTAC 
Snord100 snoRNA CTCGCTGAGGAAACTGCACGTCACCCTCCTGAAA 
Snora68 snoRNA GTGCAGTGCCCCCCAGAGTGAATCAGTAGGCTCTACAGAA 
Rnu3a snRNA AACCACTCAGACTGTGTCCTCTCCCTCTCAACCCTCAA 
Snord42b snoRNA GAGACCTGTGATGTCTTCAAAGGAACCACTGATG 
Snord83b snoRNA TGAGGAATTATTCCCTGTTGCCTTCCTTCTGAGA 
Snord110 snoRNA TTGCTCAGACACATGGAGTCGTCAGTGATCTCTCAGGG 
Snord47 snoRNA CCTCAGAAATAAAATGGAACGGTTTAAAGGTGAT 
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Antibodies 
SSRP1 Biolenends 
SUPT16 Cell signalling 
Alpha-tubulin Abcam 
β3-Tubulin Cell signalling 
MAP2 Millipore 
H3K4me3 Active motif 
 
 
7 Methods 
 
Cell culture. The E14 cell line (mESCs) was cultured at 37 °C, 7.5% CO2, on 
0.1% gelatin coated plates, in DMEM + GlutaMax™ (Gibco) with 15% fetal bovine 
serum (Gibco), MEM non- essential amino acids (Gibco), penicillin/streptomycin 
(Gibco), 550 µM 2-mercaptoethanol (Gibco), and 10 ng/ml of leukaemia inhibitory 
factor (LIF) (eBioscience). HEK293T, N2a, MEFs, NIH3T3, and B16 cell lines 
were cultured at 37 °C, 5% CO2 in DMEM + GlutaMax™ (Gibco) with 10% fetal 
bovine serum (Gibco), and penicillin/streptomycin (Gibco). Early Neuronal 
Precursor Cells (NPCs) were generated as previously described (Bibel et al., 
2007). Briefly, embryoid bodies were created with the hanging drop technique 
and were further treated with 1 µM retinoic acid (RA) for 4 days. RA-treated 
embryoid bodies were trypsinised and cultured in DMEM + GlutaMax™ (Gibco) 
with 15% fetal bovine serum without LIF for 3 days. 
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Depletion of SSRP1 from mESCs via shRNA and RNA preparation. E14 were 
transfected with lentiviral vectors containing either a scramble Control or Ssrp1 
shRNAs (MISSION® shRNA, Sigma) with the following sequences: 
Scramble 
Control 
 
CCGGGCGCGATAGCGCTAATAATTTCTCGAGAAATTATTAGCGCTATCGCGCTTTTT 
shRNA 1 
(Ssrp1) 
 
CCGGGCGTACATGCTGTGGCTTAATCTCGAGATTAAGCCACAGCATGTACGCTTTTTG 
shRNA 2 
(Ssrp1) 
 
CCGGGCAGAGGAGTTTGACAGCAATCTCGAGATTGCTGTCAAACTCCTCTGCTTTTTG 
shRNA 3 
(Ssrp1) 
 
CCGGCCGTCAGGGTATCATCTTTAACTCGAGTTAAAGATGATACCCTGACGGTTTTTG 
shRNA 4 
(Ssrp1) 
 
CCGGCCGTCAGGGTATCATCTTTAACTCGAGTTAAAGATGATACCCTGACGGTTTTTG 
 
A combination of two different Ssrp1 shRNAs was used (1&2, 3&4) at a time and 
depletion was quantified via western blotting using a monoclonal anti-Ssrp1 
antibody (Biolegends). Anti-alpha Tubulin was used as a reference control. The 
1&2 combination was used for subsequent experiments as it yielded higher 
depletion of SSRP1 levels (Extended Fig 2a,b). Generation and transfection of 
shRNA vectors was done as previously described(Ramezani & Hawley, 2002). 
Fourty-eight hours (48h) after transfection, puromycin (2 µg /ml) selection was 
applied for an additional 24h period, before cell collection and RNA preparation. 
Total RNA was obtained via phenol-chloroform extraction (QIAzol Lysis Reagent 
– QIAGEN) followed by purification via Quick-RNA™ MicroPrep (Zymo 
Research). Library preparation and ribosomal depletion were performed via the 
NEBNext Directional RNA Ultra Kit (NEB) and the RiboZero Kit (Illumina) 
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according to the manufacturer’s instructions, respectively. Four different 
biological replicates (Control or SSRP1-depleted mESCs) were prepared and 
processed for transcriptome analysis. 
 
MTT proliferation assay.  48h after transfection, different cell densities (3x104, 
2x104, 1x104) were seeded on 96-well plates (Sarstedt) along with puromycin (2 
µg /ml). Twenty-four hours later, the CellTiter 96® Non-Radioactive Cell 
Proliferation Assay kit (Promega) was used according to the manufacturer’s 
instructions in order to assess the rate of cell proliferation between the two 
conditions (Control, Ssrp1 KD). Statistical analysis was performed using a two-
tailed t-test. 
 
Transcriptome analysis in SSRP1-depleted mESCs. Sequenced reads were 
aligned to the mm10 genome via STAR (v 2.4.1b)(Dobin et al., 2013). Gene and 
exon counts were obtained from featureCounts of the Rsubread package 
(R/Bioconductor). Only reads with CPM (counts per million) > 1 were kept for 
subsequent analysis. Counts were normalised using the internal TMM 
normalisation in edgeR(Robinson, McCarthy, & Smyth, 2009) and differential 
expression was performed using the limma(Ritchie et al., 2015) package.  
Significant genes with an absolute logFC > 1 and Adjusted P.Value < 0.01 were 
considered as differentially expressed. The “No Change” gene class (n=2,179) 
was obtained from genes with an Adjusted P.Value > 0.05.  The diffSplice 
function implemented in limma was used to identify differentially spliced exons 
between the two conditions. Significant exons with an FDR < 0.001 were 
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considered as differentially spliced. Retention Introns were identified using the 
MISO (Katz, Wang, Airoldi, & Burge, 2010) (Mixture of Isoforms) probabilistic 
framework. 
 
Retention intron events. We verified the presence of retained introns in the 
Ssrp1 KD by randomly selecting ten intron retention events. The FastStart SYBR 
Green Master (Roche) was used along with the following primers to amplify via 
PCR the retained intragenic regions;  
 
Gene name Forward primer Reverse primer 
Men1 ATTTCCCAGCAGGCTTCAGG GGGATGACACGGTTGACAGC 
Dvl1 CCTGGGACTACCTCCAGACA CCTTCATGATGGATCCAATGTA 
Map4k2 GCTGCAGTCAGTCCAGGAGG TCCTGTTGCTTCAGAGTAGCC 
Ctsa GCAATACTCCGGCTACCTCA TGGGGACTCGATATACAGCA 
Pol2ri CGAAATCGGGAGTGAGTAGC GGTGGAAGAAGGAACGATCA 
Wipf2 TAGAGATGAGCAGCGGAATC TCGAGAGCTGGGGACTTGCA 
Fuz GACCCAGTGTGTGGACTGTG GACAAAGGCTGTGCCAGTGG 
Rfx5 CACCAGTTGCCCTCTCTGAA CAATTCTCTTCCTCCCATGC 
Fhod1 CACCAGGGAGCAGAGATGAT CCATCAACATTGGCCTAACC 
Tcirg1 AGCGACAGCACTCACTCCTT CAACACCCCTGCTTCCAGGC 
 
Amplified products were run on a 1.5% Agarose gel and visualized under UV. 
Band quantification was performed with ImageJ. 
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Chromatin Immunoprecipitation (ChIP) of FACT subunits. ChIP was 
performed in ~20 million ES cells, per assay, as described previously(Tessarz et 
al., 2014) with a few modifications. Briefly, cells were crosslinked with 1% 
formaldehyde for 20 min followed by quenching for 5 min with the addition of 
glycine to a final concentration of 0.125 M. After washing with PBS buffer, cells 
were collected and lysed in Cell Lysis buffer (5 mM Tris pH8.0, 85 mM KCl, 0.5% 
NP40 ) with proteinase inhibitors (10 µl/mL Phenylmethylsulfonyl fluoride (PMSF), 
1 µl/mL Leupeptin and 1 µl/mL Pepstatin). Pellets were spun for 5 min at 5000 
rpm at 4°C. Nuclei were lysed in Nuclei Lysis Buffer (1% SDS, 10 mM EDTA, 50 
mM Tris HCl) and samples were sonicated for 12 min. Samples were centrifuged 
for 20 min at 13,000 rpm at 4°C and the supernatant was diluted in IP buffer 
(0.01% SDS, 1.1% Triton-X-100, 1.2 mM EDTA, 16.7 mM Tris HCl, 167 mM 
NaCl) and the appropriate antibody was added and left overnight with rotation at 
4°C. Anti-Ssrp1 and anti-Supt16 antibodies were purchased from Biolegends 
(#609702) and Cell Signalling (#12191) respectively. Two biological replicates 
were prepared for each FACT subunit, using independent cell cultures and 
chromatin precipitations. Protein A/G Dynabeads (Invitrogen) were added for 1h 
and after extensive washed samples were eluted in Elution Buffer (1% SDS, 0.1 
M NaHCO3). 20 µL of 5 M NaCl were added and samples were reverse-
crosslinked at 65°C for 4h. Following phenol-chloroform extraction and ethanol 
precipitation, DNA was incubated at 37°C for 4h with RNAse (Sigma). 
ChIP-seq library preparation, sequencing, and peak-calling. Approximately 
10-20 ng of ChIP material was used for library preparation. End-repair and 
adaptor ligation was prepared as described previously with a few 
modifications(Tessarz et al., 2014). Double sided size selections (~200 – 650bp) 
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were performed using the MagSI-NGS Dynabeads (MagnaMedics, #MD61021) 
according to the manufacturer’s instructions. Purified adapter-ligated ChIP 
material was run on a high sensitivity DNA chip on a 2200 TapeStation (Agilent) 
to assess size distribution and adaptor contamination. 
Samples were single-end deep-sequenced and reads were aligned to the mm10 
genome using Bowtie2 (v 2.2.6) (Langmead & Salzberg, 2012). Peak-calling was 
performed using PePr (v 1.1) (Zhang, Lin, Johnson, Rozek, & Sartor, 2014) with 
peaks displaying an FDR < 10-5 considered as statistically significant. Peak 
annotation was performed via the chipenrich(Welch et al., 2014) R package with 
the following parameters (locusdef = "nearest_gene", method = "broadenrich").  
 
ChIP-seq normalisation and metagene analysis. All the ChIP-seq BAM files 
were converted to bigwig (10 bp bin) and normalised to x1 sequencing depth 
using Deeptools (v 2.4)(Ramirez et al., 2016). Blacklisted mm9 co-ordinates were 
converted to mm10 using the LiftOver tool from UCSC and were further removed 
from the analysis.  Average binding profiles were visualised using R (v 3.3.0). 
Heatmaps were generated via Deeptools. For the average profiles in Extended 
Fig 1a,b, RPKM values from Control ES RNA-seq data were divided into four 
different quantiles and the average profile for each FACT subunit was generated 
for each quantile. The Pearson’s correlation plot in Figure 1a was generated 
using all unique annotated mm10 RefSeq genes (n = 13,348) from UCSC 
(blacklisted regions were removed). The mESC promoter/enhancer regions 
identified in Shen et al(Shen et al., 2012) were used for the generation of Figure 
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1b. H3K4me3 ChIP-seq tag densities were split by k-means clustering into three 
categories in order to remove genes with low H3K4me3 density.  
 
MNase-seq following SSRP1 depletion in mESCs. ES cells were cultured and 
transfected with shRNA vectors as described above. Biological replicates were 
obtained from two independent transfection experiments for each shRNA vector. 
Briefly, ~5 million cells were crosslinked with 1% formaldehyde for 20 min 
followed by quenching for 5 min with the addition of glycine to a final 
concentration of 0.125 M. After washing with PBS buffer, cells were collected and 
lysed in Cell Lysis buffer (5 mM Tris pH8.0, 85 mM KCl, 0.5% NP40 ) with 
proteinase inhibitors (10 µl/mL Phenylmethylsulfonyl fluoride (PMSF), 1 µl/mL 
Leupeptin and 1 µl/mL Pepstatin). Nuclei were gathered by centrifugation (5000 
rpm for 2 min) and were treated with 10 Kunitz Units/106 cells of micrococcal 
nuclease (NEB, #M0247S) for 5 min at 37°C. The reaction was stopped with the 
addition of 60 µl 50 mM EDTA, 25 µl 5 M NaCl, 15 µl 20% NP-40 and incubated 
on a rotator for 1h at room temperature to release soluble nucleosomes. Samples 
were centrifuged for 5 min at 10,000 g and supernatant was transferred to a new 
tube. This centrifugation step is important to obtain highly soluble nucleosomes 
and remove nucleosome-protein complexes, which can raise bias in subsequent 
data interpretation(Carone et al., 2014) (See Extended Fig. 8). Samples were 
reverse-crosslinked by incubating overnight at 65°C with 0.5% SDS and 
proteinase K. Following phenol-chloroform extraction and ethanol precipitation, 
DNA was incubated at 37°C for 4h with RNAse (Sigma). All the samples were run 
in a 2% agarose gel and fragments <200 bp were extracted and purified using the 
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NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel) according to the 
manufacturer’s instructions.  
Purified DNA (500 ng) was used for library preparation as described above. The 
only difference was the PCR amplification step where we used the same 
conditions as mentioned in Henikoff et al (Henikoff, Belsky, Krassovsky, 
MacAlpine, & Henikoff, 2011) but with only three amplification cycles. Libraries 
were verified using a 2200 TapeStation and were paired-end deep-sequenced 
(~250 million reads per sample).  
 
MNase-seq normalisation and metagene analysis. All the MNase-seq BAM 
files were converted to bigwig, binned (1 bp), smoothed (20-bp window), and 
normalised to x1 sequencing depth using Deeptools (v 2.4). Moreover, they were 
split into two different categories according to fragment length; <80 bp 
Transcription factor (TF)-sized fragments and 135-170 bp mononucleosome 
fragments). Average nucleosome occupancy profiles were visualised using R (v 
3.3.0). For the Extended Fig 8c, the mm10 annotated exon list for 
mononucleosomal profiling was obtained from UCSC.  
 
Mass spectrometry sample preparation and analysis.  Nuclei were isolated 
from ~5 million ES cells under hypotonic conditions and samples were incubated 
overnight at 4°C with an anti-H3K4me3 antibody (Active Motif, #39159) in the 
presence of low-salt Binding buffer (150 mM NaCl, 50 mM Tris-HCl pH 8.0, 1% 
NP-40), protease inhibitors, and Protein G Dynabeads (Invitrogen). The following 
day, after several rounds of bead washing with Binding Buffer, samples were 
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incubated overnight at 37°C with Tris pH 8.8 and 300 ng Trypsin Gold (Promega). 
In total, four samples were prepared for each condition (Control, Ssrp1 KD). 
Peptides were desalted using StageTips(Rappsilber, Ishihama, & Mann, 2003)  
and dried. The peptides were resuspended in 0.1% formic acid and analyzed 
using liquid chromatography - mass spectrometry (LC-MS/MS). 
 
LC-MS/MS analysis. For mass spectrometric analysis, peptides were separated 
online on a 25 cm 75 μm ID PicoFrit analytical column (New Objective) packed 
with 1.9 μm ReproSil-Pur media (Dr. Maisch) using an EASY-nLC 1000 (Thermo 
Fisher Scientific). The column was maintained at 50°C. Buffer A and B were 0.1% 
formic acid in water and 0.1% formic acid in acetonitrile respectively. Peptides 
were separated on a segmented gradient from 5% to 25% buffer B for 45 min, 
from 25% to 35% buffer B for 8 min, and from 35% to 45% buffer B for 4 min, at 
200nl / min. Eluting peptides were analyzed on a QExactive HF mass 
spectrometer (Thermo Fisher Scientific). Peptide precursor mass to charge ratio 
(m/z) measurements (MS1) were carried out at 60000 resolution in the 300 to 
1500 m/z range. The top ten most intense precursors with charge state from 2 to 
7 only, were selected for HCD fragmentation using 27% collision energy. The m/z 
of the peptide fragments (MS2) were measured at 15000 resolution, using an 
AGC target of 1e6 and 80 ms maximum injection time. Upon fragmentation, 
precursors were put on an exclusion list for 45 seconds. 
LC-MS/MS data analysis. The raw data were analyzed with MaxQuant(Jurgen 
Cox & Mann, 2008) (v 1.5.2.8) using the integrated Andromeda search engine 
(Jürgen Cox et al., 2011). Fragmentation spectra were searched against the 
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canonical and isoform sequences of the mouse reference proteome (proteome ID 
UP000000589, downloaded August 2015) from UniProt. The database was 
automatically complemented with sequences of contaminating proteins by 
MaxQuant. For the data analysis, methionine oxidation and protein N-terminal 
acetylation were set as variable modifications. The digestion parameters were set 
to “specific” and “Trypsin/P,” allowing for cleavage after lysine and arginine, also 
when followed by proline. The minimum number of peptides and razor peptides 
for protein identification was 1; the minimum number of unique peptides was 0. 
Protein identification was performed at a peptide spectrum matches and protein 
false discovery rate of 0.01. The “second peptide” option was on in order to 
identify co-fragmented peptides. Successful identifications were transferred 
between the different raw files using the “Match between runs” option, using a 
match time window of 0.7 min. Label-free quantification (LFQ)(Jurgen Cox, Hein, 
Luber, & Paron, 2014) was performed using an LFQ minimum ratio count of 2.  
Identification of co-enriched proteins. Analysis of the label-free quantification 
results was done using the Perseus computation platform(Tyanova et al., 2016) 
(v 1.5.0.0) and R. For the analysis, LFQ intensity values were loaded in Perseus 
and all identified proteins marked as “Reverse”, “Only identified by site”, and 
“Potential contaminant” were removed. Upon log2 transformation of the LFQ 
intensity values, all proteins that contained less than four missing values in one of 
the groups (control or Ssrp1 KD) were removed. Missing values in the resulting 
subset of proteins were imputed with a width of 0.3 and down shift of 1.8. Next, 
the imputed LFQ intensities were loaded into R where a two side testing for 
enrichment was performed using limma(Kammers, Cole, Tiengwe, & Ruczinski, 
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2015; Ritchie et al., 2015). Proteins with an adjusted p-value of less than 0.05 
were designated as significantly enriched in the control or knockdown. 
 
NET-seq library preparation.  ES cells were cultured and transfected with 
shRNA vectors as described above. Biological replicates were obtained from two 
independent transfection experiments for each shRNA vector. NET-seq libraries 
were prepared as previously described(Mayer & Churchman, 2016) with a few 
modifications. Briefly, chromatin associated nascent RNA was extracted through 
cell fractionation in the presence of α-amanitin, protease and RNAase inhibitors. 
> 90% recovery of ligated RNA and cDNA was achieved from 15 % TBE-Urea 
(Invitrogen) and 10% TBE-Urea (Invitrogen), respectively, by adding RNA 
recovery buffer (Zymo Research, R1070-1-10) to the excised gel slices and 
further incubating at 70°C (1500 rpm) for 15 min. Gel slurry was transferred 
through a Zymo-Spin IV Column (Zymo Research, C1007-50) and further 
precipitated for subsequent library preparation steps. cDNA containing the 3’ end 
sequences of a subset of mature and heavily sequenced snRNAs, snoRNAs, and 
rRNAs, are specifically depleted using biotinylated DNA oligos. Oligo-depleted 
circularised cDNA was amplified via PCR (5 cycles) and double stranded DNA 
was run on a 4% low melt agarose gel. The final NET-seq library running at ~150 
bp was extracted and further purified using the ZymoClean Gel DNA recovery kit 
(Zymo Research). Sample purity and concentration was assessed in a 2200 
TapeStation and further deep sequenced in a HiSeq 2500 Illumina Platform 
(~400 million reads per replicate). 
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NET-seq analysis. All the NET-seq fastq files were processed using custom 
Python scripts (https://github.com/BradnerLab/netseq) to remove PCR duplicates 
and reads arising from RT bias. Reads mapping exactly to the last nucleotide of 
each intron and exon (Splicing intermediates) were further removed from the 
analysis. The final NET-seq BAM files were converted to bigwig (1 bp bin), 
separated by strand, and normalised to x1 sequencing depth using Deeptools (v 
2.4) with an “–Offset 1” in order to record the position of the 5’ end of the 
sequencing read. NET-seq tags sharing the same or opposite orientation with the 
TSS were assigned as ‘sense’ and ‘anti-sense’ tags, respectively.  Average Pol II 
occupancy profiles were visualised using R (v 3.3.0). In Fig 2g, the Proximal 
Promoter region was defined as -30 bp and +250 bp around the TSS. For Fig 2f, 
gene body coverage was retrieved by averaging all regions (FACT-bound and 
non-FACT-bound) +300 bp downstream of TSS (Transcription Start site) and -
200 bp upstream of TES (Transcription End Site). Comparison of the two linear 
regressions was performed by calculating the z-score via 
z =
β1 −  β2
√sβ1
2 +  sβ2
2
 
where β and 𝑠𝛽 represent the ‘slope’ and the ‘standard error of the slope’, 
respectively. P value was calculated from the respective confidence level yielded 
by the z score.  
 
Immunofluorescence and confocal microscopy. Early Neuronal Precursor 
Cells (NPCs) were generated and Ssrp1 levels were knocked-down as described 
above. Cells were fixed with 100% Ethanol for 10 min and processed for 
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immunofluorescence. Permeabilisation and blocking was performed for 1 h at 
room temperature with 1% BSA and 0.1% NP-40 in PBS. Incubation with primary 
antibodies was carried at room temperature for 2 hours by using rabbit anti-β3-
Tubulin (1:300; Cell Signaling) and mouse anti-MAP2 (1:300; Millipore.). After 
washing in blocking buffer, the secondary antibodies anti-rabbit and anti-mouse 
Alexa Fluor 568 (1:1,000; Life Technologies.) were applied for 2 h at room 
temperature. Slides were extensively washed in PBS and nuclei were 
counterstained with DAPI before mounting. Fluorescence images were acquired 
using a laser-scanning confocal microscope (TCS SP5-X; Leica), equipped with a 
white light laser, a 405-diode UV laser, and a 40× objective lens. 
 
Gene Ontology Analysis. All GO terms were retrieved from the metascape 
online platform (http://metascape.org/). 
 
Accession numbers and references of publicly available data sets. 
H3K4me3, H3K27me3, Pol II S5ph, H3K4me1, H3K27Ac, CTCF (ENCODE; 
https://www.encodeproject.org/); Ep400, Chd1, Chd2, Chd4, Chd6, Chd8, Chd9 
(de Dieuleveult et al., 2016) : GSE64825; Set1 (Cxxc1) (Denissov et al., 2014): 
GSM1258239; p53(Li et al., 2012): GSE26360; Pol II S2ph (Brookes et al., 2016): 
GSM850470; GRO-seq (Min et al., 2011): GSE27037, Smarcad1 (Xiao et al., 
2017) : GSE45338. 
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